{"gene":"TRAF1","run_date":"2026-04-28T21:42:59","timeline":{"discoveries":[{"year":1998,"finding":"NF-κB transcriptional activation induces TRAF1 (along with TRAF2, c-IAP1, c-IAP2) gene expression, and these proteins cooperatively suppress caspase-8 activation downstream of TNF-α, blocking TNF-induced apoptosis.","method":"Cotransfection/reporter assays, dominant-negative constructs, NF-κB inhibition with functional apoptosis readout","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 — clean functional KO/dominant-negative with defined pathway placement, highly cited, replicated across labs","pmids":["9733516"],"is_preprint":false},{"year":1996,"finding":"TRAF1 and TRAF2 interact with A20 (zinc finger protein) via A20's N-terminal domain binding to the conserved C-terminal TRAF domain of TRAF1/TRAF2; this recruits A20 to the TRAF2-TRAF1 complex, and A20's C-terminal zinc finger domain then inhibits NF-κB activation, providing negative feedback.","method":"Coimmunoprecipitation, mutational analysis, cotransfection NF-κB reporter assays","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP plus mutagenesis, highly cited","pmids":["8692885"],"is_preprint":false},{"year":1996,"finding":"TRAF1, TRAF2, and TRAF3 associate with EBV LMP1 at a single cytoplasmic site (aa 199–214), and TRAF1 forms heterocomplexes with TRAF2; TRAF1 uniquely coactivates NF-κB with LMP1(1-231), TRAF1/TRAF2 heteroaggregates mediate NF-κB activation, while TRAF3 negatively modulates it. A PXQXT/S motif was identified as the core TRAF-binding sequence.","method":"Coimmunoprecipitation, alanine/deletion mutagenesis, cotransfection NF-κB reporter assays, EBV-transformed B cell biochemistry","journal":"Molecular and Cellular Biology","confidence":"High","confidence_rationale":"Tier 1–2 — reciprocal Co-IP with mutagenesis, multiple orthogonal methods, highly cited","pmids":["8943365"],"is_preprint":false},{"year":2010,"finding":"Crystal structures of TRAF2:cIAP2 and TRAF1:TRAF2:cIAP2 complexes revealed that a TRAF2 trimer binds one cIAP2; TRAF1 preferentially forms a TRAF1:(TRAF2)2 heterotrimer that binds cIAP2 more strongly than TRAF2 alone; TRAF1 itself binds cIAP2 very weakly; key interface residues were confirmed by mutagenesis.","method":"X-ray crystallography, solution binding assays, site-directed mutagenesis","journal":"Molecular Cell","confidence":"High","confidence_rationale":"Tier 1 — crystal structures with mutagenesis validation, strong mechanistic evidence","pmids":["20385093"],"is_preprint":false},{"year":2001,"finding":"TRAF1-deficient mice show enhanced TNF signaling: TRAF1-/- T cells respond to TNF by proliferation and NF-κB/AP-1 activation via TNFR2 (but not TNFR1), and skin is hypersensitive to TNF-induced necrosis, demonstrating TRAF1 is a negative regulator of TNFR2-mediated TNF signaling.","method":"Knockout mouse generation, T cell functional assays, skin TNF challenge in vivo","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 — clean KO mouse with multiple defined phenotypic readouts","pmids":["11672546"],"is_preprint":false},{"year":2002,"finding":"TRAF1 regulates subcellular localization of TRAF2: upon CD40 engagement, TRAF2 translocates to lipid rafts in a RING finger-dependent manner, but TRAF1 displaces TRAF2 and CD40 from raft fractions while sustaining prolonged TRAF2 signaling. TRAF1-/- dendritic cells show increased TRAF2 degradation and attenuated secondary signaling responses.","method":"Lipid raft fractionation, TRAF1-/- dendritic cell functional assays, RING finger mutants, JNK and NF-κB activation assays","journal":"The Journal of Experimental Medicine","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including KO cells and fractionation with defined functional consequences","pmids":["12370254"],"is_preprint":false},{"year":1997,"finding":"TRAF1 overexpression in transgenic mice inhibits antigen-induced apoptosis of CD8+ T lymphocytes, demonstrating a biological role for TRAF1 as a regulator of apoptotic signals via TNFR2 signaling complex.","method":"Transgenic mouse overexpression, antigen-induced apoptosis assay in CD8 T cells","journal":"The Journal of Experimental Medicine","confidence":"High","confidence_rationale":"Tier 2 — in vivo transgenic approach with defined cellular phenotype","pmids":["9151703"],"is_preprint":false},{"year":1997,"finding":"CD30 cytoplasmic domain contains two TRAF-binding motifs: the membrane-proximal domain 1 activates NF-κB independently of TRAFs, while domain 2 (containing PXQXT-like sequences) binds TRAF1, TRAF2, and TRAF3 and activates NF-κB through TRAF1/TRAF2 but not TRAF3; full-length TRAF3 and dominant-negative TRAF1/TRAF2 inhibit NF-κB through domain 2.","method":"Deletion/point mutagenesis of CD30, cotransfection NF-κB reporter assays, dominant-negative TRAFs","journal":"Molecular and Cellular Biology","confidence":"High","confidence_rationale":"Tier 2 — mutagenesis plus dominant-negative approach with clear pathway placement","pmids":["9032281"],"is_preprint":false},{"year":2000,"finding":"TRAF1 (but not TRAF2-6) is specifically cleaved by caspase-8 at site 160LEVD163 during TNF-α- and Fas-induced apoptosis, generating a C-terminal fragment that enhances TNF receptor-1-mediated apoptosis and suppresses TRAF2-mediated NF-κB activation by acting as a dominant negative.","method":"In vitro caspase cleavage assay, site-directed mutagenesis of cleavage site, overexpression of fragments in HEK293T/HT1080 cells, NF-κB reporter assays, apoptosis assays","journal":"The Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro biochemistry plus mutagenesis plus cellular functional assays","pmids":["11098060"],"is_preprint":false},{"year":2000,"finding":"Caspase cleavage of TRAF1 after Asp-163 during FasL-induced apoptosis generates a C-terminal dominant-negative fragment that blocks TNF-induced NF-κB activation, creating a pro-apoptotic amplification loop.","method":"FasL apoptosis assay, identification of cleavage site, dominant-negative functional assay","journal":"FEBS Letters","confidence":"Medium","confidence_rationale":"Tier 2 — single lab, consistent with PMID 11098060 but independent confirmation of same mechanism","pmids":["10692572"],"is_preprint":false},{"year":1999,"finding":"TRAF1 expression is transcriptionally induced by NF-κB binding to three functional sites in the TRAF1 promoter downstream of TNF-R1, CD40, and IL-1R signaling. Overexpression of TRAF1 prolongs TNF-induced JNK activation, while a deletion mutant interferes with both NF-κB and JNK activation, indicating TRAF1 participates in feedback regulation.","method":"EMSA, promoter-luciferase reporter assays, RNase protection assays, TRAF1 overexpression/deletion constructs with JNK/NF-κB activation readouts","journal":"The Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (EMSA, reporter, functional kinase assays)","pmids":["10383449"],"is_preprint":false},{"year":1999,"finding":"TRAF1 overexpression in HEK293T cells prevents NF-κB activation by TNF, IL-1, TRAF2, and TRAF6, identifying TRAF1 as a TNF-inducible negative regulator of NF-κB signaling; TNF-induced TRAF1 upregulation was blocked by proteasome inhibitor MG-132.","method":"NF-κB reporter assays, Western blot, pharmacological inhibition","journal":"FEBS Letters","confidence":"Medium","confidence_rationale":"Tier 3 — overexpression approach, single lab, consistent with other evidence","pmids":["10544244"],"is_preprint":false},{"year":2008,"finding":"TRAF1 is required for survival signaling downstream of 4-1BB in CD8 T cells during viral infection in vivo: TRAF1-deficient CD8 T cells fail to activate ERK in response to 4-1BB ligation, leading to impaired Bcl-xL upregulation and increased Bim levels; ERK inhibition downstream of 4-1BB in wild-type cells phenocopies TRAF1 loss.","method":"TRAF1-/- mice, viral infection model (in vivo), 4-1BB ligation assays, ERK inhibitor, Bcl-xL/Bim Western blots","journal":"Journal of Immunology","confidence":"High","confidence_rationale":"Tier 2 — KO mouse with in vivo viral model, pharmacological validation, multiple orthogonal readouts","pmids":["18523273"],"is_preprint":false},{"year":2012,"finding":"TRAF1 plays opposing roles in NF-κB pathways in T cells: it is required for maximal classical NF-κB activation downstream of 4-1BB, but also restricts constitutive NIK (NF-κB-inducing kinase) activation in anti-CD3-activated T cells, limiting alternative NF-κB pathway activity. TRAF1 participates in the cIAP1/2:TRAF2:TRAF3:NIK repressor complex; 4-1BB stimulation induces cIAP1-dependent TRAF3 degradation to activate alternative NF-κB.","method":"TRAF1-/- T cells, siRNA knockdown of NIK, 4-1BB stimulation assays, cIAP1-dependent TRAF3 degradation assays","journal":"The Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 2 — KO cells plus siRNA with multiple pathway readouts, mechanistically detailed","pmids":["22570473"],"is_preprint":false},{"year":2016,"finding":"TRAF1 MATH domain directly binds to three components of the linear ubiquitin chain assembly complex (LUBAC) — SHARPIN, HOIP, and HOIL-1 — to interfere with NEMO recruitment and linear ubiquitination, thereby decreasing NF-κB activation and cytokine production in response to LPS/TLR signaling, independently of TNF. TRAF1-/- mice show increased susceptibility to LPS-induced septic shock.","method":"Direct binding assay (TRAF1 MATH domain), coimmunoprecipitation, Traf1-/- mouse LPS challenge, cytokine measurements in human monocytes with disease-associated SNP","journal":"Nature Immunology","confidence":"High","confidence_rationale":"Tier 2 — direct binding plus KO mouse plus human monocyte validation, multiple orthogonal methods","pmids":["27893701"],"is_preprint":false},{"year":2015,"finding":"LMP1 TES1 domain signaling induces association of TRAF1 with LUBAC complex and stimulates linear (M1)-linked and K63-linked polyubiquitin chain attachment to TRAF1 complexes; TRAF2 (not cIAP1/2) is critical for LUBAC recruitment to TRAF1; M1-ubiquitin binding proteins NEMO, A20, and ABIN1 associate with TRAF1 in LMP1-expressing cells. Depletion of TRAF1 or HOIP impairs LCL growth.","method":"Proteomic analysis of immunopurified TRAF1 complexes, ubiquitin linkage-specific antibodies, shRNA knockdown, LCL growth assays","journal":"PLoS Pathogens","confidence":"High","confidence_rationale":"Tier 2 — mass spectrometry proteomics plus functional validation, multiple orthogonal methods","pmids":["25996949"],"is_preprint":false},{"year":2016,"finding":"Crystal structure of the TRAF1 TRAF domain (containing both TRAF-N coiled-coil and TRAF-C domains) was solved; the TRAF-N coiled-coil domain is critical for trimer formation and stability; conserved surface residues on TRAF-C domain are binding hot spots for signaling molecule interactions.","method":"X-ray crystallography, structural analysis","journal":"Scientific Reports","confidence":"Medium","confidence_rationale":"Tier 1 — crystal structure, but limited functional mutagenesis validation in this paper","pmids":["27151821"],"is_preprint":false},{"year":2017,"finding":"Crystal structure of TRAF1 TRAF domain in complex with TANK peptide revealed that TANK binds TRAF1 using the minimal consensus Px(Q/E)xT motif; TANK peptide interacts with both TRAF1 and TRAF2 with similar micromolar affinity.","method":"X-ray crystallography, quantitative binding experiments (ITC or SPR implied)","journal":"FEBS Letters","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with quantitative binding validation","pmids":["28155233"],"is_preprint":false},{"year":2013,"finding":"TRAF1 directly interacts with ASK1 (apoptosis signal-regulating kinase 1), and increased neuronal TRAF1 after ischemia promotes neuronal apoptosis by activating the JNK pro-death pathway and inhibiting Akt survival signaling through ASK1.","method":"Co-immunoprecipitation (direct TRAF1-ASK1 interaction), TRAF1-/- and TRAF1 transgenic mice, genetic in vivo stroke model, pathway activation assays","journal":"Nature Communications","confidence":"High","confidence_rationale":"Tier 2 — Co-IP plus KO and transgenic mouse in vivo models with multiple pathway readouts","pmids":["24284943"],"is_preprint":false},{"year":2016,"finding":"TRAF1 promotes hepatic steatosis through direct activation of the ASK1-P38/JNK signaling cascade; ASK1 inhibition abrogates the effect of TRAF1 on insulin dysfunction, inflammation, and hepatic lipid accumulation.","method":"Global TRAF1-/- and liver-specific TRAF1 transgenic mice, HFD/ob/ob models, ASK1 inhibitor rescue experiments, in vitro palmitate-treated hepatocytes","journal":"Journal of Hepatology","confidence":"High","confidence_rationale":"Tier 2 — KO and transgenic mice with pharmacological rescue, multiple readouts","pmids":["26860405"],"is_preprint":false},{"year":2014,"finding":"TRAF1 mediates hepatic ischemia/reperfusion injury by activating the ASK1/JNK pro-death pathway and promoting NF-κB-mediated inflammatory responses; TRAF1 deficiency is liver protective, while hepatocyte-specific TRAF1 overexpression aggravates injury.","method":"Mouse hepatic I/R model, TRAF1-/- mice, hepatocyte-specific TRAF1 transgenic mice, in vitro hepatocyte assays, pathway activation Western blots","journal":"Cell Death & Disease","confidence":"High","confidence_rationale":"Tier 2 — KO and transgenic mice with defined mechanistic pathway","pmids":["25321474"],"is_preprint":false},{"year":2003,"finding":"The caspase-generated C-terminal TRAF1 fragment (TRAF domain alone) acts as a general inhibitor of NF-κB activation by directly targeting the IKK complex; full-length TRAF1 interacts with IKK2 via its N-TRAF domain and is constitutively associated with the IKK complex; the cleavage product (not full-length TRAF1) inhibits IKK activation.","method":"Coimmunoprecipitation of TRAF1 with IKK complex, cotransfection reporter assays, kinase assays, caspase cleavage fragment overexpression","journal":"The Journal of Biological Chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP and kinase assays, single lab with multiple methods","pmids":["12709429"],"is_preprint":false},{"year":2008,"finding":"PKN1 serine/threonine kinase phosphorylates TRAF1 in vitro and in vivo; this phosphorylation is required for attenuation of constitutive IKK and JNK activity; phosphorylation enables TRAF1 recruitment to TNFR2, and mutagenesis of the phospho-acceptor residue abrogates PKN1-dependent TNFR2 recruitment, establishing PKN1 as a writer for TRAF1 phosphorylation.","method":"In vitro kinase assay, in vivo phosphorylation, site-directed mutagenesis, IKK/JNK activity assays, TNFR2 coimmunoprecipitation","journal":"Genes to Cells","confidence":"High","confidence_rationale":"Tier 1 — in vitro kinase assay plus mutagenesis plus cellular functional assays","pmids":["18429822"],"is_preprint":false},{"year":2001,"finding":"Caspase-cleaved TRAF1 C-terminal fragment coimmunoprecipitates with TRAF2 released from the TNF-R1 complex during prolonged TNF treatment, sequestering TRAF2 and rendering cells sensitive to TNF-induced apoptosis.","method":"Coimmunoprecipitation of cleaved TRAF1 with TRAF2, TNF stimulation time course, apoptosis assays","journal":"Biochemical and Biophysical Research Communications","confidence":"Medium","confidence_rationale":"Tier 3 — single Co-IP with functional apoptosis readout, single lab","pmids":["11181075"],"is_preprint":false},{"year":2006,"finding":"TRAF1 interacts with TRIF (via TRAF-C domain of TRAF1 and TIR domain of TRIF) and negatively regulates TRIF/TLR3-mediated NF-κB and IFN-β activation; TRIF-induced caspase-dependent cleavage of TRAF1 generates an N-terminal fragment that mediates the inhibitory effect; caspase cleavage site mutation or caspase inhibitor abolishes TRAF1-mediated TRIF signaling inhibition.","method":"Yeast two-hybrid identification, coimmunoprecipitation, mutagenesis, overexpression reporter assays, caspase inhibitor experiments","journal":"European Journal of Immunology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple methods but single lab","pmids":["16323247"],"is_preprint":false},{"year":2005,"finding":"TRAF1 associates with NIP45 (NFAT-interacting protein) in the cytoplasm and prevents its translocation to the nucleus, thereby limiting Th2 cytokine (IL-4) transcription; TRAF1-/- T cells have elevated nuclear NIP45 and produce more Th2 cytokines.","method":"TRAF1-/- T cells, cytokine assays, biochemical fractionation showing TRAF1-NIP45 cytoplasmic association, T cell transfer in vivo model","journal":"International Immunology","confidence":"Medium","confidence_rationale":"Tier 2 — KO plus biochemical interaction, but NIP45 association shown by single Co-IP approach","pmids":["16352630"],"is_preprint":false},{"year":2010,"finding":"TRAF1 interacts with IKK2 (N-terminal aa 1-228 of TRAF1 binds C-terminal aa 466-756 of IKK2); coexpression of TRAF1 and TRAF2 at different ratios affects TRAF2 clustering and NF-κB activity in a dose-dependent manner, suggesting TRAF1:TRAF2 stoichiometry regulates NF-κB.","method":"Yeast two-hybrid, mammalian two-hybrid, coimmunoprecipitation, fluorescence imaging of TRAF2 clustering, NF-κB reporter assays","journal":"PLoS One","confidence":"Medium","confidence_rationale":"Tier 2 — multiple interaction methods with functional readout, single lab","pmids":["20856938"],"is_preprint":false},{"year":2007,"finding":"NF-κB2 mutant p80HT binds the TRAF1 promoter in vivo (chromatin immunoprecipitation) and activates TRAF1 transcription; elevated TRAF1 mediates the anti-apoptotic activity of p80HT, as TRAF1 knockdown abrogates p80HT-mediated anti-apoptosis and restores B cell homeostasis in p80HT transgenic mice.","method":"Transgenic mouse model, ChIP, siRNA knockdown of TRAF1, apoptosis assays, TRAF1 and p80HT double-mutant genetic analysis","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — ChIP plus transgenic/KO genetic approach with functional rescue","pmids":["17405906"],"is_preprint":false},{"year":2013,"finding":"A novel TRAF1-ALK fusion protein (Exon 6 of TRAF1 fused to Exon 20 of ALK) was identified by deep RNA sequencing in ALCL; the fusion transcript was confirmed by Sanger sequencing and the fusion protein visualized by Western blot, resulting in cytoplasmic ALK localization.","method":"Deep RNA sequencing, Sanger sequencing confirmation, Western blot","journal":"Genes, Chromosomes & Cancer","confidence":"Medium","confidence_rationale":"Tier 2 — molecular characterization of fusion protein at nucleic acid and protein level","pmids":["23999969"],"is_preprint":false},{"year":2018,"finding":"TRAF1 regulates the BRAF/MEK/ERK signaling pathway in non-small cell lung cancer by affecting TRAF2-mediated Lys48-linked ubiquitination of BRAF; loss of TRAF1 decelerates tumor invasion in a urethane-induced lung carcinogenesis model.","method":"TRAF1-/- mouse lung carcinogenesis model, ubiquitination assays (Lys48-linked), BRAF/MEK/ERK pathway activation assays","journal":"Cancer Research","confidence":"Medium","confidence_rationale":"Tier 2 — KO mouse plus ubiquitination assay, but TRAF2-mediated BRAF ubiquitination link is indirect","pmids":["29748372"],"is_preprint":false},{"year":2017,"finding":"TRAF1 is required for solar UV-induced ERK5 phosphorylation and AP-1 (c-Fos/c-Jun) activation; TRAF1 expression enhances ubiquitination of ERK5 on Lys184, which is necessary for ERK5 kinase activity; TRAF1-/- mice show significant inhibition of UV-induced skin tumor formation.","method":"TRAF1-/- mouse skin carcinogenesis model, ERK5 ubiquitination assay at Lys184, ERK5 kinase activity assays, AP-1 reporter assays","journal":"Journal of Investigative Dermatology","confidence":"Medium","confidence_rationale":"Tier 2 — KO mouse plus ubiquitination assay with mutagenesis of Lys184","pmids":["28131816"],"is_preprint":false},{"year":2003,"finding":"TRAF1 is a critical regulator of JNK/AP-1 signaling downstream of LMP1 TES1 domain in TRAF1-positive lymphoma cells; JNK activation by LMP1 TES1 is blocked by dominant-negative TRAF2 but not TRAF5, and requires TRAF1 reconstitution in TRAF1-negative epithelial cells. This TRAF1 role is specific to LMP1 TES1 and not to CD40 or LMP1 TRADD-interacting domain.","method":"Dominant-negative TRAF constructs, TRAF1-negative vs TRAF1-positive cell lines, TRAF1 reconstitution, JNK activation assays","journal":"Journal of Virology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple cell line contexts and dominant-negative constructs, single lab","pmids":["12502848"],"is_preprint":false},{"year":2010,"finding":"TRAF1 deficiency in both hematopoietic and vascular resident cells attenuates atherosclerosis by impairing monocyte adhesion to endothelium; TRAF1-/- endothelial cells and monocytes show reduced adhesion molecule expression (ICAM-1, VCAM-1), reduced actin polymerization, and reduced CD29 expression.","method":"TRAF1-/-/LDLR-/- mouse atherosclerosis model, bone marrow transplantation, static/dynamic adhesion assays, siRNA in human cells","journal":"Circulation","confidence":"High","confidence_rationale":"Tier 2 — KO mouse with bone marrow transplantation plus in vitro mechanistic dissection, multiple orthogonal methods","pmids":["20421522"],"is_preprint":false},{"year":2010,"finding":"TRAF1 mRNA translation is regulated by an internal ribosome entry segment (IRES) in its unusually long 5'-UTR (element located between nt -392 and -322 is essential); the chemotherapeutic drug vincristine induces TRAF1 expression by regulating cytoplasmic localization of polypyrimidine tract binding protein, stimulating IRES-dependent translation.","method":"Bicistronic reporter assays, deletion mapping of IRES, vincristine treatment, PTB localization assays","journal":"Nucleic Acids Research","confidence":"Medium","confidence_rationale":"Tier 2 — IRES reporter assays with mutagenesis and deletion mapping, single lab","pmids":["20413583"],"is_preprint":false},{"year":2019,"finding":"TRAF1 promotes myocardial ischemia/reperfusion injury by activating ASK1-mediated JNK/p38 MAPK cascades; TRAF1-/- mice are protected from I/R-induced cardiac dysfunction, inflammation, and cardiomyocyte death, while TRAF1 overexpression in primary cardiomyocytes enhances hypoxia/reoxygenation-induced apoptosis and inflammation.","method":"TRAF1-/- mouse I/R model, primary cardiomyocyte overexpression, ASK1-JNK/p38 pathway Western blots","journal":"Journal of the American Heart Association","confidence":"Medium","confidence_rationale":"Tier 2 — KO mouse plus in vitro overexpression with defined signaling pathway, single lab","pmids":["31650881"],"is_preprint":false},{"year":2019,"finding":"4-1BB-induced accumulation of CD8 effector T cells in the lung and formation of tissue-resident memory T cells requires TRAF1 and mTOR (rapamycin-sensitive); both Ag and costimulation must be delivered locally, demonstrating TRAF1-dependent mTOR pathway activation downstream of 4-1BB in effector T cell persistence.","method":"TRAF1-/- mice, influenza infection/prime-boost model, rapamycin treatment, intratracheal 4-1BB stimulation, lung T cell quantification","journal":"Journal of Immunology","confidence":"Medium","confidence_rationale":"Tier 2 — KO mouse in vivo model with pharmacological inhibition, but pathway placement partially indirect","pmids":["30867239"],"is_preprint":false},{"year":2011,"finding":"TRAF1 is specifically lost from virus-specific CD8 T cells during chronic HIV/LCMV infection; TGF-β induces posttranslational loss of TRAF1, while IL-7 restores TRAF1 levels; TRAF1 is required for the effect of combination IL-7/anti-4-1BB therapy in reducing viral load.","method":"Human HIV patient samples, LCMV mouse model, TRAF1 knockdown in viral controllers, TGF-β/IL-7 treatment, adoptive transfer of TRAF1+ vs TRAF1- memory T cells","journal":"The Journal of Experimental Medicine","confidence":"High","confidence_rationale":"Tier 2 — human and mouse models, adoptive transfer with TRAF1+/- cells, multiple orthogonal approaches","pmids":["22184633"],"is_preprint":false}],"current_model":"TRAF1 is an NF-κB–induced adaptor protein that lacks the RING finger domain of other TRAF family members and functions as a context-dependent positive or negative regulator of TNF receptor superfamily (especially TNFR2, 4-1BB, CD40) and Toll-like receptor signaling: it forms TRAF1:(TRAF2)₂ heterotrimers that bind cIAP1/2 and modulate TRAF2 subcellular localization and stability, recruits LUBAC to dampen NEMO linear ubiquitination and NF-κB activation downstream of TLRs, is cleaved by caspase-8 at Asp163 to generate a dominant-negative fragment that inhibits NF-κB and amplifies apoptosis, is phosphorylated by PKN1 to facilitate TNFR2 recruitment, directly interacts with ASK1 to promote JNK/p38 pro-death signaling, and is transcriptionally regulated by NF-κB as well as translationally regulated via a 5'-UTR IRES element."},"narrative":{"teleology":[{"year":1996,"claim":"Establishing that TRAF1 forms heterocomplexes with TRAF2 and recruits the NF-κB inhibitor A20, revealing TRAF1 as a scaffold for negative feedback in NF-κB signaling rather than a simple signal transducer.","evidence":"Reciprocal Co-IP with mutagenesis and NF-κB reporter assays in transfected cells; EBV LMP1 cytoplasmic domain dissection identified the PXQXT/S TRAF-binding motif","pmids":["8692885","8943365"],"confidence":"High","gaps":["No structural basis for TRAF1-TRAF2 heterotrimerization at this stage","Stoichiometry of heterocomplex unknown","In vivo relevance of A20 recruitment via TRAF1 not tested"]},{"year":1997,"claim":"Demonstrating in vivo that TRAF1 overexpression inhibits antigen-induced CD8 T cell apoptosis and that TRAF1/TRAF2 activate NF-κB through CD30 domain 2, placing TRAF1 as a costimulatory adaptor for TNFR superfamily members.","evidence":"Transgenic mouse CD8 T cell apoptosis assay; CD30 cytoplasmic domain mutagenesis with NF-κB reporters","pmids":["9151703","9032281"],"confidence":"High","gaps":["Receptor-specific versus general anti-apoptotic role not distinguished","Endogenous TRAF1 loss-of-function not yet tested"]},{"year":1998,"claim":"Identifying TRAF1 as a direct NF-κB transcriptional target that cooperates with TRAF2/cIAP1/cIAP2 to suppress caspase-8, establishing the NF-κB → TRAF1 anti-apoptotic feedback loop.","evidence":"Cotransfection/reporter assays with dominant-negative constructs and NF-κB inhibition, apoptosis readout in TNF-stimulated cells","pmids":["9733516"],"confidence":"High","gaps":["Mechanism of caspase-8 suppression by TRAF1 not defined","Relative contribution of TRAF1 vs cIAP1/2 unresolved"]},{"year":1999,"claim":"Mapping NF-κB binding sites in the TRAF1 promoter and showing that TRAF1 overexpression prolongs JNK activation while inhibiting NF-κB, revealing TRAF1 as a pathway-selective feedback regulator.","evidence":"EMSA, promoter-luciferase reporters, RNase protection assays, JNK/NF-κB activation with TRAF1 overexpression/deletion constructs","pmids":["10383449","10544244"],"confidence":"High","gaps":["Mechanism by which TRAF1 prolongs JNK while restraining NF-κB not resolved","Overexpression artifacts cannot be excluded for NF-κB inhibition"]},{"year":2000,"claim":"Discovering that caspase-8 cleaves TRAF1 at Asp163 during death receptor signaling, generating a C-terminal dominant-negative fragment that blocks NF-κB and amplifies apoptosis — converting TRAF1 from protector to pro-death effector.","evidence":"In vitro caspase cleavage assays, site-directed mutagenesis of LEVD163, overexpression of fragments with NF-κB and apoptosis readouts","pmids":["11098060","10692572"],"confidence":"High","gaps":["Physiological stoichiometry of cleavage fragments unclear","Whether caspase-8 cleavage of TRAF1 is required for apoptosis in vivo untested"]},{"year":2001,"claim":"TRAF1 knockout mice revealed that TRAF1 is a negative regulator of TNFR2 signaling in vivo: TRAF1-deficient T cells hyper-respond to TNF via TNFR2, and skin shows TNF hypersensitivity, settling the question of whether TRAF1 is predominantly pro-survival or inhibitory.","evidence":"TRAF1-/- mouse generation, T cell proliferation/NF-κB/AP-1 assays, skin TNF necrosis challenge","pmids":["11672546"],"confidence":"High","gaps":["Whether TRAF1 loss affects TNFR1 signaling in vivo remains unclear","Cell-type-specific versus systemic contributions not dissected"]},{"year":2002,"claim":"Resolving how TRAF1 modulates TRAF2 function: TRAF1 displaces TRAF2 and CD40 from lipid rafts and prevents TRAF2 degradation, sustaining prolonged signaling — explaining the paradox of TRAF1 acting as both positive and negative regulator depending on signal duration.","evidence":"Lipid raft fractionation in TRAF1-/- dendritic cells, RING finger mutants, JNK and NF-κB time-course assays","pmids":["12370254"],"confidence":"High","gaps":["Whether raft displacement is direct or mediated by another factor unknown","Kinetics of TRAF2 stabilization by TRAF1 not quantified"]},{"year":2003,"claim":"Identifying the IKK complex as a direct target of caspase-cleaved TRAF1: the C-terminal fragment inhibits IKK activation, while full-length TRAF1 constitutively associates with IKK2 via its N-TRAF domain, mechanistically explaining how cleavage switches TRAF1 function.","evidence":"Co-IP of TRAF1 with IKK complex, kinase assays, fragment overexpression with NF-κB reporters","pmids":["12709429"],"confidence":"Medium","gaps":["Endogenous cleavage fragment–IKK interaction not demonstrated","Structural basis for N-TRAF domain–IKK2 interaction unknown"]},{"year":2008,"claim":"Establishing TRAF1 as essential for 4-1BB costimulatory signaling in CD8 T cells: TRAF1 is required for ERK activation, Bcl-xL upregulation, and survival during viral infection, and PKN1 phosphorylation of TRAF1 controls its recruitment to TNFR2.","evidence":"TRAF1-/- mice with viral infection model and 4-1BB ligation; in vitro/in vivo kinase assays with phospho-site mutagenesis for PKN1–TRAF1","pmids":["18523273","18429822"],"confidence":"High","gaps":["PKN1 phosphorylation site on TRAF1 not mapped to a specific residue in the publication","Whether PKN1 regulation of TRAF1 applies to 4-1BB pathway untested"]},{"year":2010,"claim":"Structural resolution of TRAF1:(TRAF2)₂:cIAP2 complex showed that TRAF1 forms a 1:2 heterotrimer with TRAF2 that enhances cIAP2 binding, providing the atomic basis for TRAF1's modulatory role; concurrently, TRAF1 was shown to regulate atherosclerosis through monocyte-endothelial adhesion and to undergo IRES-dependent translation.","evidence":"X-ray crystallography with mutagenesis (TRAF1:TRAF2:cIAP2); TRAF1-/-/LDLR-/- mouse atherosclerosis model with bone marrow chimeras; bicistronic IRES reporter assays with deletion mapping","pmids":["20385093","20421522","20413583"],"confidence":"High","gaps":["Full-length TRAF1:TRAF2 complex structure not available","IRES trans-acting factors beyond PTB not identified","Whether TRAF1:TRAF2 stoichiometry changes in vivo during signaling unknown"]},{"year":2012,"claim":"Demonstrating that TRAF1 has opposing roles in classical versus alternative NF-κB: it promotes classical NF-κB via 4-1BB but restricts constitutive NIK activation by participating in the cIAP1/2:TRAF2:TRAF3:NIK degradation complex, unifying apparently contradictory phenotypes.","evidence":"TRAF1-/- T cells, NIK siRNA rescue, 4-1BB stimulation with cIAP1-dependent TRAF3 degradation assays","pmids":["22570473"],"confidence":"High","gaps":["Direct biochemical demonstration of TRAF1 within the NIK degradation complex lacking","Whether TRAF1's role in alternative NF-κB extends beyond T cells unknown"]},{"year":2013,"claim":"Revealing a non-immune function: TRAF1 directly binds ASK1 and promotes neuronal apoptosis after ischemia by activating JNK and inhibiting Akt, expanding TRAF1's role beyond immune signaling to stress-induced cell death.","evidence":"Co-IP of TRAF1-ASK1, TRAF1-/- and transgenic mice in stroke model, JNK/Akt pathway assays","pmids":["24284943"],"confidence":"High","gaps":["Whether TRAF1 activates ASK1 directly or relieves thioredoxin inhibition unknown","Structural basis for TRAF1-ASK1 interaction not determined"]},{"year":2015,"claim":"Demonstrating that TRAF1 serves as a platform for LUBAC recruitment in EBV LMP1 signaling, leading to M1- and K63-linked ubiquitination of TRAF1 complexes and recruitment of NEMO, A20, and ABIN1 — connecting TRAF1 to linear ubiquitin-dependent signaling.","evidence":"Proteomic analysis of immunopurified TRAF1 complexes, ubiquitin linkage-specific antibodies, shRNA knockdown with LCL growth assays","pmids":["25996949"],"confidence":"High","gaps":["Whether TRAF1 is itself a direct ubiquitination substrate or scaffold for other substrates not resolved","LUBAC recruitment mechanism (direct vs TRAF2-mediated) debated"]},{"year":2016,"claim":"Establishing TRAF1 as a direct negative regulator of TLR/LUBAC signaling independent of TNF: the TRAF1 MATH domain binds SHARPIN, HOIP, and HOIL-1 to block NEMO linear ubiquitination and NF-κB activation; TRAF1-/- mice are hypersusceptible to LPS septic shock.","evidence":"Direct binding assays of TRAF1 MATH domain with LUBAC components, Co-IP, TRAF1-/- mouse LPS challenge, human monocyte disease-SNP validation","pmids":["27893701"],"confidence":"High","gaps":["Whether TRAF1-LUBAC interaction is competitive or allosteric not defined","Role of TRAF1 in other TLR pathways beyond TLR4 not explored"]},{"year":2016,"claim":"Extending TRAF1-ASK1 axis to metabolic disease: TRAF1 promotes hepatic steatosis through ASK1-p38/JNK activation, and ASK1 inhibition fully rescues TRAF1-driven insulin resistance and lipid accumulation.","evidence":"Global TRAF1-/- and liver-specific transgenic mice on HFD/ob/ob background, ASK1 pharmacological inhibitor rescue","pmids":["26860405"],"confidence":"High","gaps":["Direct phosphorylation or activation mechanism of ASK1 by TRAF1 not defined","Whether TRAF1-ASK1 interaction in liver involves TRAF2 not tested"]},{"year":2017,"claim":"Crystal structures of TRAF1 TRAF domain alone and in complex with TANK peptide confirmed the Px(Q/E)xT binding motif and showed similar affinity to TRAF2, providing the first structural framework for receptor/adaptor selectivity.","evidence":"X-ray crystallography with quantitative binding measurements","pmids":["27151821","28155233"],"confidence":"High","gaps":["No structure of full-length TRAF1","How TRAF1 distinguishes between different receptor cytoplasmic tails structurally unclear"]},{"year":2019,"claim":"Extending TRAF1-ASK1 pro-death axis to cardiac ischemia/reperfusion injury, and establishing TRAF1-dependent mTOR activation downstream of 4-1BB for tissue-resident memory CD8 T cell formation in the lung.","evidence":"TRAF1-/- mouse cardiac I/R model with cardiomyocyte overexpression; TRAF1-/- mice in influenza prime-boost model with rapamycin","pmids":["31650881","30867239"],"confidence":"Medium","gaps":["Whether TRAF1-mTOR link is direct or mediated through ERK/PI3K unknown","Cardiac TRAF1-ASK1 mechanism largely inferred from hepatic/neuronal models"]},{"year":null,"claim":"Key open questions include: the structural basis of full-length TRAF1 and how it differs from other TRAFs lacking the RING domain; the molecular mechanism by which TRAF1 activates ASK1; the relative contributions of TRAF1-LUBAC versus TRAF1-TRAF2 complexes to receptor-specific NF-κB regulation; and whether post-translational modifications beyond PKN1 phosphorylation and caspase cleavage control TRAF1 switching between pro-survival and pro-death functions.","evidence":"","pmids":[],"confidence":"Low","gaps":["No full-length TRAF1 structure available","Mechanism of ASK1 activation by TRAF1 not biochemically defined","Comprehensive post-translational modification map of TRAF1 lacking"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,2,3,13,14]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[4,5,11,14,22]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[5,25]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[5]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,2,4,7,10,13,14,18]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[12,14,32,36]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[0,6,8,9,18]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[28,29,30]}],"complexes":["TRAF1:(TRAF2)2:cIAP2 heterotrimer","cIAP1/2:TRAF2:TRAF3:NIK repressor complex","TRAF1:LUBAC complex"],"partners":["TRAF2","BIRC3","TNFAIP3","MAP3K5","SHARPIN","RNF31","RBCK1","PKN1"],"other_free_text":[]},"mechanistic_narrative":"TRAF1 is an NF-κB–inducible adaptor protein that lacks the RING finger domain present in other TRAF family members and functions as a context-dependent modulator of TNF receptor superfamily, Toll-like receptor, and stress kinase signaling. TRAF1 forms TRAF1:(TRAF2)₂ heterotrimers that enhance cIAP2 recruitment, regulate TRAF2 subcellular localization and stability at lipid rafts, and modulate NF-κB activation downstream of TNFR2, CD40, 4-1BB, and CD30 [PMID:20385093, PMID:12370254, PMID:11672546, PMID:18523273]. TRAF1 recruits LUBAC to dampen NEMO linear ubiquitination and NF-κB activation in TLR signaling, interacts with ASK1 to promote JNK/p38 pro-death cascades in ischemia and metabolic disease, and is cleaved by caspase-8 at Asp163 to generate a dominant-negative fragment that inhibits IKK-dependent NF-κB activation and amplifies apoptosis [PMID:27893701, PMID:24284943, PMID:11098060, PMID:12709429]. TRAF1 expression is transcriptionally driven by NF-κB binding to its promoter and translationally regulated via a 5′-UTR IRES element, establishing feedback circuits that tune inflammatory and survival signaling [PMID:10383449, PMID:9733516, PMID:20413583]."},"prefetch_data":{"uniprot":{"accession":"Q13077","full_name":"TNF receptor-associated factor 1","aliases":["Epstein-Barr virus-induced protein 6"],"length_aa":416,"mass_kda":46.2,"function":"Adapter molecule that regulates the activation of NF-kappa-B and JNK. Plays a role in the regulation of cell survival and apoptosis. The heterotrimer formed by TRAF1 and TRAF2 is part of a E3 ubiquitin-protein ligase complex that promotes ubiquitination of target proteins, such as MAP3K14. The TRAF1/TRAF2 complex recruits the antiapoptotic E3 protein-ubiquitin ligases BIRC2 and BIRC3 to TNFRSF1B/TNFR2","subcellular_location":"","url":"https://www.uniprot.org/uniprotkb/Q13077/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TRAF1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/TRAF1","total_profiled":1310},"omim":[{"mim_id":"615614","title":"MMS22-LIKE PROTEIN; MMS22L","url":"https://www.omim.org/entry/615614"},{"mim_id":"613197","title":"TRAF-TYPE ZINC FINGER DOMAIN-CONTAINING 1; TRAFD1","url":"https://www.omim.org/entry/613197"},{"mim_id":"611749","title":"ZINC FINGER RANBP2-TYPE DOMAIN-CONTAINING PROTEIN 1; ZRANB1","url":"https://www.omim.org/entry/611749"},{"mim_id":"611748","title":"OTU DOMAIN-CONTAINING PROTEIN 7B; OTUD7B","url":"https://www.omim.org/entry/611748"},{"mim_id":"611211","title":"RECEPTOR EXPRESSED IN LYMPHOID TISSUES; RELT","url":"https://www.omim.org/entry/611211"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/TRAF1"},"hgnc":{"alias_symbol":["EBI6"],"prev_symbol":[]},"alphafold":{"accession":"Q13077","domains":[{"cath_id":"2.60.210.10","chopping":"264-413","consensus_level":"high","plddt":96.188,"start":264,"end":413}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13077","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q13077-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q13077-F1-predicted_aligned_error_v6.png","plddt_mean":79.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TRAF1","jax_strain_url":"https://www.jax.org/strain/search?query=TRAF1"},"sequence":{"accession":"Q13077","fasta_url":"https://rest.uniprot.org/uniprotkb/Q13077.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q13077/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13077"}},"corpus_meta":[{"pmid":"9733516","id":"PMC_9733516","title":"NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation.","date":"1998","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/9733516","citation_count":2437,"is_preprint":false},{"pmid":"17804836","id":"PMC_17804836","title":"TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study.","date":"2007","source":"The New England journal of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/17804836","citation_count":675,"is_preprint":false},{"pmid":"8943365","id":"PMC_8943365","title":"Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation.","date":"1996","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8943365","citation_count":422,"is_preprint":false},{"pmid":"8692885","id":"PMC_8692885","title":"The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation.","date":"1996","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8692885","citation_count":369,"is_preprint":false},{"pmid":"17880261","id":"PMC_17880261","title":"A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis.","date":"2007","source":"PLoS medicine","url":"https://pubmed.ncbi.nlm.nih.gov/17880261","citation_count":223,"is_preprint":false},{"pmid":"9032281","id":"PMC_9032281","title":"Induction of nuclear factor kappaB by the CD30 receptor is mediated by TRAF1 and TRAF2.","date":"1997","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9032281","citation_count":185,"is_preprint":false},{"pmid":"20385093","id":"PMC_20385093","title":"Crystal structures of the TRAF2: cIAP2 and the TRAF1: TRAF2: cIAP2 complexes: affinity, specificity, and regulation.","date":"2010","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/20385093","citation_count":173,"is_preprint":false},{"pmid":"11672546","id":"PMC_11672546","title":"TRAF1 is a negative regulator of TNF signaling. enhanced TNF signaling in TRAF1-deficient mice.","date":"2001","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/11672546","citation_count":156,"is_preprint":false},{"pmid":"9151858","id":"PMC_9151858","title":"Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3.","date":"1997","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/9151858","citation_count":146,"is_preprint":false},{"pmid":"10383449","id":"PMC_10383449","title":"The human tumor necrosis factor (TNF) receptor-associated factor 1 gene (TRAF1) is up-regulated by cytokines of the TNF ligand family and modulates TNF-induced activation of NF-kappaB and c-Jun N-terminal kinase.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10383449","citation_count":144,"is_preprint":false},{"pmid":"18523273","id":"PMC_18523273","title":"ERK-dependent Bim modulation downstream of the 4-1BB-TRAF1 signaling axis is a critical mediator of CD8 T cell survival in vivo.","date":"2008","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/18523273","citation_count":133,"is_preprint":false},{"pmid":"12370254","id":"PMC_12370254","title":"Regulation of the subcellular localization of tumor necrosis factor receptor-associated factor (TRAF)2 by TRAF1 reveals mechanisms of TRAF2 signaling.","date":"2002","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12370254","citation_count":119,"is_preprint":false},{"pmid":"26860405","id":"PMC_26860405","title":"Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis.","date":"2016","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/26860405","citation_count":116,"is_preprint":false},{"pmid":"9151703","id":"PMC_9151703","title":"A regulatory role for TRAF1 in antigen-induced apoptosis of T cells.","date":"1997","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/9151703","citation_count":116,"is_preprint":false},{"pmid":"24284943","id":"PMC_24284943","title":"TRAF1 is a critical regulator of cerebral ischaemia-reperfusion injury and neuronal death.","date":"2013","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/24284943","citation_count":103,"is_preprint":false},{"pmid":"14585960","id":"PMC_14585960","title":"Discrete functions of TRAF1 and TRAF2 in Drosophila melanogaster mediated by c-Jun N-terminal kinase and NF-kappaB-dependent signaling pathways.","date":"2003","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/14585960","citation_count":98,"is_preprint":false},{"pmid":"17332487","id":"PMC_17332487","title":"TRAF-1, -2, -3, -5, and -6 are induced in atherosclerotic plaques and differentially mediate proinflammatory functions of CD40L in endothelial cells.","date":"2007","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17332487","citation_count":92,"is_preprint":false},{"pmid":"35538475","id":"PMC_35538475","title":"N6-methyladenosine-modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14-dependent manner in renal cell carcinoma.","date":"2022","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/35538475","citation_count":90,"is_preprint":false},{"pmid":"30619326","id":"PMC_30619326","title":"TRAF1 Signaling in Human Health and Disease.","date":"2018","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30619326","citation_count":86,"is_preprint":false},{"pmid":"9168896","id":"PMC_9168896","title":"Binding sites of cytoplasmic effectors TRAF1, 2, and 3 on CD30 and other members of the TNF receptor superfamily.","date":"1997","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/9168896","citation_count":86,"is_preprint":false},{"pmid":"18432273","id":"PMC_18432273","title":"STAT4 but not TRAF1/C5 variants influence the risk of developing rheumatoid arthritis and systemic lupus erythematosus in Colombians.","date":"2008","source":"Genes and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/18432273","citation_count":80,"is_preprint":false},{"pmid":"22570473","id":"PMC_22570473","title":"Opposing roles for TRAF1 in the alternative versus classical NF-κB pathway in T cells.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22570473","citation_count":79,"is_preprint":false},{"pmid":"10544244","id":"PMC_10544244","title":"TRAF1 is a TNF inducible regulator of NF-kappaB activation.","date":"1999","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/10544244","citation_count":77,"is_preprint":false},{"pmid":"16891304","id":"PMC_16891304","title":"The inhibitor of apoptosis protein fusion c-IAP2.MALT1 stimulates NF-kappaB activation independently of TRAF1 AND TRAF2.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16891304","citation_count":75,"is_preprint":false},{"pmid":"18625278","id":"PMC_18625278","title":"Association of a TRAF1 and a STAT4 gene polymorphism with increased risk for rheumatoid arthritis in a genetically homogeneous population.","date":"2008","source":"Human immunology","url":"https://pubmed.ncbi.nlm.nih.gov/18625278","citation_count":70,"is_preprint":false},{"pmid":"21905002","id":"PMC_21905002","title":"Gene-gene interaction of BLK, TNFSF4, TRAF1, TNFAIP3, and REL in systemic lupus erythematosus.","date":"2012","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/21905002","citation_count":70,"is_preprint":false},{"pmid":"14981539","id":"PMC_14981539","title":"Regulation of phorbol ester-mediated TRAF1 induction in human colon cancer cells through a PKC/RAF/ERK/NF-kappaB-dependent pathway.","date":"2004","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/14981539","citation_count":69,"is_preprint":false},{"pmid":"25996949","id":"PMC_25996949","title":"TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation.","date":"2015","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/25996949","citation_count":68,"is_preprint":false},{"pmid":"25566937","id":"PMC_25566937","title":"A genetic study on C5-TRAF1 and progression of joint damage in rheumatoid arthritis.","date":"2015","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/25566937","citation_count":67,"is_preprint":false},{"pmid":"8943059","id":"PMC_8943059","title":"Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activation.","date":"1996","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8943059","citation_count":64,"is_preprint":false},{"pmid":"27893701","id":"PMC_27893701","title":"The signaling adaptor TRAF1 negatively regulates Toll-like receptor signaling and this underlies its role in rheumatic disease.","date":"2016","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27893701","citation_count":62,"is_preprint":false},{"pmid":"11098060","id":"PMC_11098060","title":"TRAF1 is a substrate of caspases activated during tumor necrosis factor receptor-alpha-induced apoptosis.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11098060","citation_count":61,"is_preprint":false},{"pmid":"10692572","id":"PMC_10692572","title":"Caspase-induced inactivation of the anti-apoptotic TRAF1 during Fas ligand-mediated apoptosis.","date":"2000","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/10692572","citation_count":60,"is_preprint":false},{"pmid":"20421522","id":"PMC_20421522","title":"Tumor necrosis factor receptor-associated factor 1 (TRAF1) deficiency attenuates atherosclerosis in mice by impairing monocyte recruitment to the vessel wall.","date":"2010","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/20421522","citation_count":57,"is_preprint":false},{"pmid":"12502848","id":"PMC_12502848","title":"TRAF1 is a critical regulator of JNK signaling by the TRAF-binding domain of the Epstein-Barr virus-encoded latent infection membrane protein 1 but not CD40.","date":"2003","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/12502848","citation_count":56,"is_preprint":false},{"pmid":"22184633","id":"PMC_22184633","title":"Loss of the signaling adaptor TRAF1 causes CD8+ T cell dysregulation during human and murine chronic infection.","date":"2011","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22184633","citation_count":55,"is_preprint":false},{"pmid":"26673966","id":"PMC_26673966","title":"A novel long non-coding RNA in the rheumatoid arthritis risk locus TRAF1-C5 influences C5 mRNA levels.","date":"2015","source":"Genes and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/26673966","citation_count":53,"is_preprint":false},{"pmid":"17197926","id":"PMC_17197926","title":"Expression of TRAF1 and nuclear c-Rel distinguishes primary mediastinal large cell lymphoma from other types of diffuse large B-cell lymphoma.","date":"2007","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/17197926","citation_count":52,"is_preprint":false},{"pmid":"19433411","id":"PMC_19433411","title":"The TRAF1-C5 region on chromosome 9q33 is associated with multiple autoimmune diseases.","date":"2009","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/19433411","citation_count":50,"is_preprint":false},{"pmid":"16323247","id":"PMC_16323247","title":"TNF receptor-associated factor-1 (TRAF1) negatively regulates Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF)-mediated signaling.","date":"2006","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16323247","citation_count":50,"is_preprint":false},{"pmid":"19540595","id":"PMC_19540595","title":"TRAF1 is involved in the classical NF-kappaB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells.","date":"2009","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/19540595","citation_count":48,"is_preprint":false},{"pmid":"29748372","id":"PMC_29748372","title":"TRAF1 Is Critical for Regulating the BRAF/MEK/ERK Pathway in Non-Small Cell Lung Carcinogenesis.","date":"2018","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/29748372","citation_count":46,"is_preprint":false},{"pmid":"34749775","id":"PMC_34749775","title":"DNMT1-induced miR-378a-3p silencing promotes angiogenesis via the NF-κB signaling pathway by targeting TRAF1 in hepatocellular carcinoma.","date":"2021","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/34749775","citation_count":46,"is_preprint":false},{"pmid":"34759347","id":"PMC_34759347","title":"RNA demethylase ALKBH5 promotes tumorigenesis in multiple myeloma via TRAF1-mediated activation of NF-κB and MAPK signaling pathways.","date":"2021","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/34759347","citation_count":45,"is_preprint":false},{"pmid":"23999969","id":"PMC_23999969","title":"Novel TRAF1-ALK fusion identified by deep RNA sequencing of anaplastic large cell lymphoma.","date":"2013","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/23999969","citation_count":45,"is_preprint":false},{"pmid":"17633014","id":"PMC_17633014","title":"TRAF1 and its biological functions.","date":"2007","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/17633014","citation_count":45,"is_preprint":false},{"pmid":"10544141","id":"PMC_10544141","title":"The A20 protein interacts with the Epstein-Barr virus latent membrane protein 1 (LMP1) and alters the LMP1/TRAF1/TRADD complex.","date":"1999","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/10544141","citation_count":44,"is_preprint":false},{"pmid":"12754742","id":"PMC_12754742","title":"Differential expression and function of A20 and TRAF1 in Hodgkin lymphoma and anaplastic large cell lymphoma and their induction by CD30 stimulation.","date":"2003","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/12754742","citation_count":43,"is_preprint":false},{"pmid":"18593758","id":"PMC_18593758","title":"The TRAF1/C5 region is a risk factor for polyarthritis in juvenile idiopathic arthritis.","date":"2008","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/18593758","citation_count":43,"is_preprint":false},{"pmid":"17405906","id":"PMC_17405906","title":"NF-kappaB2 mutation targets TRAF1 to induce lymphomagenesis.","date":"2007","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/17405906","citation_count":42,"is_preprint":false},{"pmid":"31650881","id":"PMC_31650881","title":"TRAF1 Exacerbates Myocardial Ischemia Reperfusion Injury via ASK1-JNK/p38 Signaling.","date":"2019","source":"Journal of the American Heart Association","url":"https://pubmed.ncbi.nlm.nih.gov/31650881","citation_count":42,"is_preprint":false},{"pmid":"25321474","id":"PMC_25321474","title":"TRAF1 is a key mediator for hepatic ischemia/reperfusion injury.","date":"2014","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/25321474","citation_count":42,"is_preprint":false},{"pmid":"12023442","id":"PMC_12023442","title":"TRAF1: lord without a RING.","date":"2002","source":"Science's STKE : signal transduction knowledge environment","url":"https://pubmed.ncbi.nlm.nih.gov/12023442","citation_count":40,"is_preprint":false},{"pmid":"10657935","id":"PMC_10657935","title":"Tumor necrosis factor-alpha-induced lung cell expression of antiapoptotic genes TRAF1 and cIAP2.","date":"2000","source":"American journal of respiratory cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10657935","citation_count":40,"is_preprint":false},{"pmid":"25533804","id":"PMC_25533804","title":"A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation.","date":"2014","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/25533804","citation_count":39,"is_preprint":false},{"pmid":"21968398","id":"PMC_21968398","title":"TRAF1/C5, eNOS, C1q, but not STAT4 and PTPN22 gene polymorphisms are associated with genetic susceptibility to systemic lupus erythematosus in Turkey.","date":"2011","source":"Human immunology","url":"https://pubmed.ncbi.nlm.nih.gov/21968398","citation_count":39,"is_preprint":false},{"pmid":"19116907","id":"PMC_19116907","title":"Association of the TRAF1/C5 locus with increased mortality, particularly from malignancy or sepsis, in patients with rheumatoid arthritis.","date":"2009","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/19116907","citation_count":38,"is_preprint":false},{"pmid":"15644776","id":"PMC_15644776","title":"TRAF1 expression and c-Rel activation are useful adjuncts in distinguishing classical Hodgkin lymphoma from a subset of morphologically or immunophenotypically similar lymphomas.","date":"2005","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/15644776","citation_count":38,"is_preprint":false},{"pmid":"30524877","id":"PMC_30524877","title":"TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer.","date":"2017","source":"Oncoimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/30524877","citation_count":36,"is_preprint":false},{"pmid":"12709429","id":"PMC_12709429","title":"Caspase-mediated cleavage converts the tumor necrosis factor (TNF) receptor-associated factor (TRAF)-1 from a selective modulator of TNF receptor signaling to a general inhibitor of NF-kappaB activation.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12709429","citation_count":36,"is_preprint":false},{"pmid":"18429822","id":"PMC_18429822","title":"Negative regulation of constitutive NF-kappaB and JNK signaling by PKN1-mediated phosphorylation of TRAF1.","date":"2008","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/18429822","citation_count":35,"is_preprint":false},{"pmid":"19336421","id":"PMC_19336421","title":"Association study of TRAF1-C5 polymorphisms with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese.","date":"2009","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/19336421","citation_count":34,"is_preprint":false},{"pmid":"27151821","id":"PMC_27151821","title":"Crystal structure of TRAF1 TRAF domain and its implications in the TRAF1-mediated intracellular signaling pathway.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27151821","citation_count":32,"is_preprint":false},{"pmid":"30867239","id":"PMC_30867239","title":"4-1BB Regulates Effector CD8 T Cell Accumulation in the Lung Tissue through a TRAF1-, mTOR-, and Antigen-Dependent Mechanism to Enhance Tissue-Resident Memory T Cell Formation during Respiratory Influenza Infection.","date":"2019","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/30867239","citation_count":32,"is_preprint":false},{"pmid":"29207620","id":"PMC_29207620","title":"TXNDC5 is a cervical tumor susceptibility gene that stimulates cell migration, vasculogenic mimicry and angiogenesis by down-regulating SERPINF1 and TRAF1 expression.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29207620","citation_count":31,"is_preprint":false},{"pmid":"24952347","id":"PMC_24952347","title":"DNMT3L interacts with transcription factors to target DNMT3L/DNMT3B to specific DNA sequences: role of the DNMT3L/DNMT3B/p65-NFκB complex in the (de-)methylation of TRAF1.","date":"2014","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/24952347","citation_count":30,"is_preprint":false},{"pmid":"28470428","id":"PMC_28470428","title":"Genome-wide DNA methylation analysis of articular chondrocytes identifies TRAF1, CTGF, and CX3CL1 genes as hypomethylated in osteoarthritis.","date":"2017","source":"Clinical rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/28470428","citation_count":29,"is_preprint":false},{"pmid":"11028545","id":"PMC_11028545","title":"Inhibited neutrophil apoptosis: proteasome dependent NF-kappaB translocation is required for TRAF-1 synthesis.","date":"2000","source":"Shock (Augusta, Ga.)","url":"https://pubmed.ncbi.nlm.nih.gov/11028545","citation_count":28,"is_preprint":false},{"pmid":"16352630","id":"PMC_16352630","title":"TRAF1 regulates Th2 differentiation, allergic inflammation and nuclear localization of the Th2 transcription factor, NIP45.","date":"2005","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16352630","citation_count":27,"is_preprint":false},{"pmid":"22196377","id":"PMC_22196377","title":"Influence of TRAF1/C5 and STAT4 genes polymorphisms on susceptibility and severity of rheumatoid arthritis in Egyptian population.","date":"2011","source":"Cellular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/22196377","citation_count":26,"is_preprint":false},{"pmid":"11181075","id":"PMC_11181075","title":"Caspase-cleaved TRAF1 negatively regulates the antiapoptotic signals of TRAF2 during TNF-induced cell death.","date":"2001","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11181075","citation_count":25,"is_preprint":false},{"pmid":"20856938","id":"PMC_20856938","title":"Interaction of the TNFR-receptor associated factor TRAF1 with I-kappa B kinase-2 and TRAF2 indicates a regulatory function for NF-kappa B signaling.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20856938","citation_count":25,"is_preprint":false},{"pmid":"20822712","id":"PMC_20822712","title":"Lack of association of PTPN22, STAT4 and TRAF1/C5 gene polymorphisms with cardiovascular risk in rheumatoid arthritis.","date":"2010","source":"Clinical and experimental rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/20822712","citation_count":24,"is_preprint":false},{"pmid":"11118894","id":"PMC_11118894","title":"Dynamic expression of Drosophila TRAF1 during embryogenesis and larval development.","date":"2001","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/11118894","citation_count":23,"is_preprint":false},{"pmid":"19401279","id":"PMC_19401279","title":"Susceptibility variants for rheumatoid arthritis in the TRAF1-C5 and 6q23 loci: a meta-analysis.","date":"2009","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/19401279","citation_count":23,"is_preprint":false},{"pmid":"22810054","id":"PMC_22810054","title":"Patient samples of renal cell carcinoma show reduced expression of TRAF1 compared with normal kidney and functional studies in vitro indicate TRAF1 promotes apoptosis: potential for targeted therapy.","date":"2012","source":"Pathology","url":"https://pubmed.ncbi.nlm.nih.gov/22810054","citation_count":23,"is_preprint":false},{"pmid":"34627385","id":"PMC_34627385","title":"SPION-MSCs enhance therapeutic efficacy in sepsis by regulating MSC-expressed TRAF1-dependent macrophage polarization.","date":"2021","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/34627385","citation_count":22,"is_preprint":false},{"pmid":"17392826","id":"PMC_17392826","title":"Differential expression of TRAF1 aids in the distinction of cutaneous CD30-positive lymphoproliferations.","date":"2007","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/17392826","citation_count":21,"is_preprint":false},{"pmid":"37664606","id":"PMC_37664606","title":"Elabela inhibits TRAF1/NF-κB induced oxidative DNA damage to promote diabetic foot ulcer wound healing.","date":"2023","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/37664606","citation_count":20,"is_preprint":false},{"pmid":"17328785","id":"PMC_17328785","title":"TRAF1 regulates recruitment of lymphocytes and, to a lesser extent, neutrophils, myeloid dendritic cells and monocytes to the lung airways following lipopolysaccharide inhalation.","date":"2007","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/17328785","citation_count":20,"is_preprint":false},{"pmid":"27060717","id":"PMC_27060717","title":"The Upregulation of TRAF1 Induced by Helicobacter pylori Plays an Antiapoptotic Effect on the Infected Cells.","date":"2016","source":"Helicobacter","url":"https://pubmed.ncbi.nlm.nih.gov/27060717","citation_count":20,"is_preprint":false},{"pmid":"29093082","id":"PMC_29093082","title":"According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1low HCV-Specific CD8+ Cell Reactivity.","date":"2018","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/29093082","citation_count":19,"is_preprint":false},{"pmid":"35194031","id":"PMC_35194031","title":"FXR1 can bind with the CFIm25/CFIm68 complex and promote the progression of urothelial carcinoma of the bladder by stabilizing TRAF1 mRNA.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/35194031","citation_count":19,"is_preprint":false},{"pmid":"29657313","id":"PMC_29657313","title":"Curcumin Attenuates Inflammation in a Severe Acute Pancreatitis Animal Model by Regulating TRAF1/ASK1 Signaling.","date":"2018","source":"Medical science monitor : international medical journal of experimental and clinical research","url":"https://pubmed.ncbi.nlm.nih.gov/29657313","citation_count":19,"is_preprint":false},{"pmid":"20030635","id":"PMC_20030635","title":"The TRAF1/C5 locus confers risk for familial and severe alopecia areata.","date":"2009","source":"The British journal of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/20030635","citation_count":19,"is_preprint":false},{"pmid":"12782762","id":"PMC_12782762","title":"Epstein-Barr virus encoded latent membrane protein 1 (LMP1) and TNF receptor associated factors (TRAF): colocalisation of LMP1 and TRAF1 in primary EBV infection and in EBV associated Hodgkin lymphoma.","date":"2003","source":"Molecular pathology : MP","url":"https://pubmed.ncbi.nlm.nih.gov/12782762","citation_count":19,"is_preprint":false},{"pmid":"23321589","id":"PMC_23321589","title":"Association study of TRAF1/C5 polymorphism (rs10818488) with susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis.","date":"2013","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/23321589","citation_count":18,"is_preprint":false},{"pmid":"11395135","id":"PMC_11395135","title":"Identification and characterization of two CD40-inducible enhancers in the mouse TRAF1 gene locus.","date":"2000","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11395135","citation_count":18,"is_preprint":false},{"pmid":"9300817","id":"PMC_9300817","title":"Organization of the human tumour necrosis factor receptor-associated factor 1 (TRAF1) gene and mapping to chromosome 9q33-34.","date":"1997","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/9300817","citation_count":18,"is_preprint":false},{"pmid":"32982301","id":"PMC_32982301","title":"PRDX1 is a Tumor Suppressor for Nasopharyngeal Carcinoma by Inhibiting PI3K/AKT/TRAF1 Signaling.","date":"2020","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/32982301","citation_count":17,"is_preprint":false},{"pmid":"30173777","id":"PMC_30173777","title":"Mir-483 inhibits colon cancer cell proliferation and migration by targeting TRAF1.","date":"2018","source":"The Kaohsiung journal of medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30173777","citation_count":16,"is_preprint":false},{"pmid":"10499814","id":"PMC_10499814","title":"Structure of the murine TRAF1 gene.","date":"1999","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10499814","citation_count":16,"is_preprint":false},{"pmid":"28131816","id":"PMC_28131816","title":"TRAF1 Is Critical for DMBA/Solar UVR-Induced Skin Carcinogenesis.","date":"2017","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/28131816","citation_count":16,"is_preprint":false},{"pmid":"32093731","id":"PMC_32093731","title":"TRAF1 suppresses antifungal immunity through CXCL1-mediated neutrophil recruitment during Candida albicans intradermal infection.","date":"2020","source":"Cell communication and signaling : CCS","url":"https://pubmed.ncbi.nlm.nih.gov/32093731","citation_count":16,"is_preprint":false},{"pmid":"30560327","id":"PMC_30560327","title":"miR-214 Down-Regulation Promoted Hypoxia/Reoxygenation-Induced Hepatocyte Apoptosis Through TRAF1/ASK1/JNK Pathway.","date":"2018","source":"Digestive diseases and sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30560327","citation_count":15,"is_preprint":false},{"pmid":"28155233","id":"PMC_28155233","title":"Molecular basis for TANK recognition by TRAF1 revealed by the crystal structure of TRAF1/TANK complex.","date":"2017","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/28155233","citation_count":15,"is_preprint":false},{"pmid":"24321457","id":"PMC_24321457","title":"A single nucleotide polymorphism of TRAF1 predicts the clinical response to anti-TNF treatment in Japanese patients with rheumatoid arthritis.","date":"2013","source":"Clinical and experimental rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/24321457","citation_count":15,"is_preprint":false},{"pmid":"22820624","id":"PMC_22820624","title":"Associations between TNFSF4 and TRAF1-C5 gene polymorphisms and systemic lupus erythematosus: a meta-analysis.","date":"2012","source":"Human immunology","url":"https://pubmed.ncbi.nlm.nih.gov/22820624","citation_count":15,"is_preprint":false},{"pmid":"20413583","id":"PMC_20413583","title":"Translation of TRAF1 is regulated by IRES-dependent mechanism and stimulated by vincristine.","date":"2010","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/20413583","citation_count":14,"is_preprint":false},{"pmid":"29506272","id":"PMC_29506272","title":"Inhibition of MicroRNA-23b Attenuates Immunosuppression During Late Sepsis Through NIK, TRAF1, and XIAP.","date":"2018","source":"The Journal of infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/29506272","citation_count":14,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":53137,"output_tokens":8958,"usd":0.146891},"stage2":{"model":"claude-opus-4-6","input_tokens":12909,"output_tokens":4770,"usd":0.275693},"total_usd":0.422584,"stage1_batch_id":"msgbatch_01RPbVc9PDH9zQmYK5Hs6srm","stage2_batch_id":"msgbatch_01JVbVLzeKN2yVrsGp3zC8aM","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"NF-κB transcriptional activation induces TRAF1 (along with TRAF2, c-IAP1, c-IAP2) gene expression, and these proteins cooperatively suppress caspase-8 activation downstream of TNF-α, blocking TNF-induced apoptosis.\",\n      \"method\": \"Cotransfection/reporter assays, dominant-negative constructs, NF-κB inhibition with functional apoptosis readout\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean functional KO/dominant-negative with defined pathway placement, highly cited, replicated across labs\",\n      \"pmids\": [\"9733516\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"TRAF1 and TRAF2 interact with A20 (zinc finger protein) via A20's N-terminal domain binding to the conserved C-terminal TRAF domain of TRAF1/TRAF2; this recruits A20 to the TRAF2-TRAF1 complex, and A20's C-terminal zinc finger domain then inhibits NF-κB activation, providing negative feedback.\",\n      \"method\": \"Coimmunoprecipitation, mutational analysis, cotransfection NF-κB reporter assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP plus mutagenesis, highly cited\",\n      \"pmids\": [\"8692885\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"TRAF1, TRAF2, and TRAF3 associate with EBV LMP1 at a single cytoplasmic site (aa 199–214), and TRAF1 forms heterocomplexes with TRAF2; TRAF1 uniquely coactivates NF-κB with LMP1(1-231), TRAF1/TRAF2 heteroaggregates mediate NF-κB activation, while TRAF3 negatively modulates it. A PXQXT/S motif was identified as the core TRAF-binding sequence.\",\n      \"method\": \"Coimmunoprecipitation, alanine/deletion mutagenesis, cotransfection NF-κB reporter assays, EBV-transformed B cell biochemistry\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — reciprocal Co-IP with mutagenesis, multiple orthogonal methods, highly cited\",\n      \"pmids\": [\"8943365\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Crystal structures of TRAF2:cIAP2 and TRAF1:TRAF2:cIAP2 complexes revealed that a TRAF2 trimer binds one cIAP2; TRAF1 preferentially forms a TRAF1:(TRAF2)2 heterotrimer that binds cIAP2 more strongly than TRAF2 alone; TRAF1 itself binds cIAP2 very weakly; key interface residues were confirmed by mutagenesis.\",\n      \"method\": \"X-ray crystallography, solution binding assays, site-directed mutagenesis\",\n      \"journal\": \"Molecular Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structures with mutagenesis validation, strong mechanistic evidence\",\n      \"pmids\": [\"20385093\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"TRAF1-deficient mice show enhanced TNF signaling: TRAF1-/- T cells respond to TNF by proliferation and NF-κB/AP-1 activation via TNFR2 (but not TNFR1), and skin is hypersensitive to TNF-induced necrosis, demonstrating TRAF1 is a negative regulator of TNFR2-mediated TNF signaling.\",\n      \"method\": \"Knockout mouse generation, T cell functional assays, skin TNF challenge in vivo\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO mouse with multiple defined phenotypic readouts\",\n      \"pmids\": [\"11672546\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"TRAF1 regulates subcellular localization of TRAF2: upon CD40 engagement, TRAF2 translocates to lipid rafts in a RING finger-dependent manner, but TRAF1 displaces TRAF2 and CD40 from raft fractions while sustaining prolonged TRAF2 signaling. TRAF1-/- dendritic cells show increased TRAF2 degradation and attenuated secondary signaling responses.\",\n      \"method\": \"Lipid raft fractionation, TRAF1-/- dendritic cell functional assays, RING finger mutants, JNK and NF-κB activation assays\",\n      \"journal\": \"The Journal of Experimental Medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including KO cells and fractionation with defined functional consequences\",\n      \"pmids\": [\"12370254\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"TRAF1 overexpression in transgenic mice inhibits antigen-induced apoptosis of CD8+ T lymphocytes, demonstrating a biological role for TRAF1 as a regulator of apoptotic signals via TNFR2 signaling complex.\",\n      \"method\": \"Transgenic mouse overexpression, antigen-induced apoptosis assay in CD8 T cells\",\n      \"journal\": \"The Journal of Experimental Medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo transgenic approach with defined cellular phenotype\",\n      \"pmids\": [\"9151703\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"CD30 cytoplasmic domain contains two TRAF-binding motifs: the membrane-proximal domain 1 activates NF-κB independently of TRAFs, while domain 2 (containing PXQXT-like sequences) binds TRAF1, TRAF2, and TRAF3 and activates NF-κB through TRAF1/TRAF2 but not TRAF3; full-length TRAF3 and dominant-negative TRAF1/TRAF2 inhibit NF-κB through domain 2.\",\n      \"method\": \"Deletion/point mutagenesis of CD30, cotransfection NF-κB reporter assays, dominant-negative TRAFs\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis plus dominant-negative approach with clear pathway placement\",\n      \"pmids\": [\"9032281\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"TRAF1 (but not TRAF2-6) is specifically cleaved by caspase-8 at site 160LEVD163 during TNF-α- and Fas-induced apoptosis, generating a C-terminal fragment that enhances TNF receptor-1-mediated apoptosis and suppresses TRAF2-mediated NF-κB activation by acting as a dominant negative.\",\n      \"method\": \"In vitro caspase cleavage assay, site-directed mutagenesis of cleavage site, overexpression of fragments in HEK293T/HT1080 cells, NF-κB reporter assays, apoptosis assays\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro biochemistry plus mutagenesis plus cellular functional assays\",\n      \"pmids\": [\"11098060\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Caspase cleavage of TRAF1 after Asp-163 during FasL-induced apoptosis generates a C-terminal dominant-negative fragment that blocks TNF-induced NF-κB activation, creating a pro-apoptotic amplification loop.\",\n      \"method\": \"FasL apoptosis assay, identification of cleavage site, dominant-negative functional assay\",\n      \"journal\": \"FEBS Letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — single lab, consistent with PMID 11098060 but independent confirmation of same mechanism\",\n      \"pmids\": [\"10692572\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"TRAF1 expression is transcriptionally induced by NF-κB binding to three functional sites in the TRAF1 promoter downstream of TNF-R1, CD40, and IL-1R signaling. Overexpression of TRAF1 prolongs TNF-induced JNK activation, while a deletion mutant interferes with both NF-κB and JNK activation, indicating TRAF1 participates in feedback regulation.\",\n      \"method\": \"EMSA, promoter-luciferase reporter assays, RNase protection assays, TRAF1 overexpression/deletion constructs with JNK/NF-κB activation readouts\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (EMSA, reporter, functional kinase assays)\",\n      \"pmids\": [\"10383449\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"TRAF1 overexpression in HEK293T cells prevents NF-κB activation by TNF, IL-1, TRAF2, and TRAF6, identifying TRAF1 as a TNF-inducible negative regulator of NF-κB signaling; TNF-induced TRAF1 upregulation was blocked by proteasome inhibitor MG-132.\",\n      \"method\": \"NF-κB reporter assays, Western blot, pharmacological inhibition\",\n      \"journal\": \"FEBS Letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — overexpression approach, single lab, consistent with other evidence\",\n      \"pmids\": [\"10544244\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"TRAF1 is required for survival signaling downstream of 4-1BB in CD8 T cells during viral infection in vivo: TRAF1-deficient CD8 T cells fail to activate ERK in response to 4-1BB ligation, leading to impaired Bcl-xL upregulation and increased Bim levels; ERK inhibition downstream of 4-1BB in wild-type cells phenocopies TRAF1 loss.\",\n      \"method\": \"TRAF1-/- mice, viral infection model (in vivo), 4-1BB ligation assays, ERK inhibitor, Bcl-xL/Bim Western blots\",\n      \"journal\": \"Journal of Immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse with in vivo viral model, pharmacological validation, multiple orthogonal readouts\",\n      \"pmids\": [\"18523273\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"TRAF1 plays opposing roles in NF-κB pathways in T cells: it is required for maximal classical NF-κB activation downstream of 4-1BB, but also restricts constitutive NIK (NF-κB-inducing kinase) activation in anti-CD3-activated T cells, limiting alternative NF-κB pathway activity. TRAF1 participates in the cIAP1/2:TRAF2:TRAF3:NIK repressor complex; 4-1BB stimulation induces cIAP1-dependent TRAF3 degradation to activate alternative NF-κB.\",\n      \"method\": \"TRAF1-/- T cells, siRNA knockdown of NIK, 4-1BB stimulation assays, cIAP1-dependent TRAF3 degradation assays\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO cells plus siRNA with multiple pathway readouts, mechanistically detailed\",\n      \"pmids\": [\"22570473\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"TRAF1 MATH domain directly binds to three components of the linear ubiquitin chain assembly complex (LUBAC) — SHARPIN, HOIP, and HOIL-1 — to interfere with NEMO recruitment and linear ubiquitination, thereby decreasing NF-κB activation and cytokine production in response to LPS/TLR signaling, independently of TNF. TRAF1-/- mice show increased susceptibility to LPS-induced septic shock.\",\n      \"method\": \"Direct binding assay (TRAF1 MATH domain), coimmunoprecipitation, Traf1-/- mouse LPS challenge, cytokine measurements in human monocytes with disease-associated SNP\",\n      \"journal\": \"Nature Immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct binding plus KO mouse plus human monocyte validation, multiple orthogonal methods\",\n      \"pmids\": [\"27893701\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"LMP1 TES1 domain signaling induces association of TRAF1 with LUBAC complex and stimulates linear (M1)-linked and K63-linked polyubiquitin chain attachment to TRAF1 complexes; TRAF2 (not cIAP1/2) is critical for LUBAC recruitment to TRAF1; M1-ubiquitin binding proteins NEMO, A20, and ABIN1 associate with TRAF1 in LMP1-expressing cells. Depletion of TRAF1 or HOIP impairs LCL growth.\",\n      \"method\": \"Proteomic analysis of immunopurified TRAF1 complexes, ubiquitin linkage-specific antibodies, shRNA knockdown, LCL growth assays\",\n      \"journal\": \"PLoS Pathogens\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mass spectrometry proteomics plus functional validation, multiple orthogonal methods\",\n      \"pmids\": [\"25996949\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Crystal structure of the TRAF1 TRAF domain (containing both TRAF-N coiled-coil and TRAF-C domains) was solved; the TRAF-N coiled-coil domain is critical for trimer formation and stability; conserved surface residues on TRAF-C domain are binding hot spots for signaling molecule interactions.\",\n      \"method\": \"X-ray crystallography, structural analysis\",\n      \"journal\": \"Scientific Reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure, but limited functional mutagenesis validation in this paper\",\n      \"pmids\": [\"27151821\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Crystal structure of TRAF1 TRAF domain in complex with TANK peptide revealed that TANK binds TRAF1 using the minimal consensus Px(Q/E)xT motif; TANK peptide interacts with both TRAF1 and TRAF2 with similar micromolar affinity.\",\n      \"method\": \"X-ray crystallography, quantitative binding experiments (ITC or SPR implied)\",\n      \"journal\": \"FEBS Letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with quantitative binding validation\",\n      \"pmids\": [\"28155233\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"TRAF1 directly interacts with ASK1 (apoptosis signal-regulating kinase 1), and increased neuronal TRAF1 after ischemia promotes neuronal apoptosis by activating the JNK pro-death pathway and inhibiting Akt survival signaling through ASK1.\",\n      \"method\": \"Co-immunoprecipitation (direct TRAF1-ASK1 interaction), TRAF1-/- and TRAF1 transgenic mice, genetic in vivo stroke model, pathway activation assays\",\n      \"journal\": \"Nature Communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP plus KO and transgenic mouse in vivo models with multiple pathway readouts\",\n      \"pmids\": [\"24284943\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"TRAF1 promotes hepatic steatosis through direct activation of the ASK1-P38/JNK signaling cascade; ASK1 inhibition abrogates the effect of TRAF1 on insulin dysfunction, inflammation, and hepatic lipid accumulation.\",\n      \"method\": \"Global TRAF1-/- and liver-specific TRAF1 transgenic mice, HFD/ob/ob models, ASK1 inhibitor rescue experiments, in vitro palmitate-treated hepatocytes\",\n      \"journal\": \"Journal of Hepatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO and transgenic mice with pharmacological rescue, multiple readouts\",\n      \"pmids\": [\"26860405\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"TRAF1 mediates hepatic ischemia/reperfusion injury by activating the ASK1/JNK pro-death pathway and promoting NF-κB-mediated inflammatory responses; TRAF1 deficiency is liver protective, while hepatocyte-specific TRAF1 overexpression aggravates injury.\",\n      \"method\": \"Mouse hepatic I/R model, TRAF1-/- mice, hepatocyte-specific TRAF1 transgenic mice, in vitro hepatocyte assays, pathway activation Western blots\",\n      \"journal\": \"Cell Death & Disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO and transgenic mice with defined mechanistic pathway\",\n      \"pmids\": [\"25321474\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The caspase-generated C-terminal TRAF1 fragment (TRAF domain alone) acts as a general inhibitor of NF-κB activation by directly targeting the IKK complex; full-length TRAF1 interacts with IKK2 via its N-TRAF domain and is constitutively associated with the IKK complex; the cleavage product (not full-length TRAF1) inhibits IKK activation.\",\n      \"method\": \"Coimmunoprecipitation of TRAF1 with IKK complex, cotransfection reporter assays, kinase assays, caspase cleavage fragment overexpression\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP and kinase assays, single lab with multiple methods\",\n      \"pmids\": [\"12709429\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"PKN1 serine/threonine kinase phosphorylates TRAF1 in vitro and in vivo; this phosphorylation is required for attenuation of constitutive IKK and JNK activity; phosphorylation enables TRAF1 recruitment to TNFR2, and mutagenesis of the phospho-acceptor residue abrogates PKN1-dependent TNFR2 recruitment, establishing PKN1 as a writer for TRAF1 phosphorylation.\",\n      \"method\": \"In vitro kinase assay, in vivo phosphorylation, site-directed mutagenesis, IKK/JNK activity assays, TNFR2 coimmunoprecipitation\",\n      \"journal\": \"Genes to Cells\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinase assay plus mutagenesis plus cellular functional assays\",\n      \"pmids\": [\"18429822\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Caspase-cleaved TRAF1 C-terminal fragment coimmunoprecipitates with TRAF2 released from the TNF-R1 complex during prolonged TNF treatment, sequestering TRAF2 and rendering cells sensitive to TNF-induced apoptosis.\",\n      \"method\": \"Coimmunoprecipitation of cleaved TRAF1 with TRAF2, TNF stimulation time course, apoptosis assays\",\n      \"journal\": \"Biochemical and Biophysical Research Communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single Co-IP with functional apoptosis readout, single lab\",\n      \"pmids\": [\"11181075\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"TRAF1 interacts with TRIF (via TRAF-C domain of TRAF1 and TIR domain of TRIF) and negatively regulates TRIF/TLR3-mediated NF-κB and IFN-β activation; TRIF-induced caspase-dependent cleavage of TRAF1 generates an N-terminal fragment that mediates the inhibitory effect; caspase cleavage site mutation or caspase inhibitor abolishes TRAF1-mediated TRIF signaling inhibition.\",\n      \"method\": \"Yeast two-hybrid identification, coimmunoprecipitation, mutagenesis, overexpression reporter assays, caspase inhibitor experiments\",\n      \"journal\": \"European Journal of Immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods but single lab\",\n      \"pmids\": [\"16323247\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"TRAF1 associates with NIP45 (NFAT-interacting protein) in the cytoplasm and prevents its translocation to the nucleus, thereby limiting Th2 cytokine (IL-4) transcription; TRAF1-/- T cells have elevated nuclear NIP45 and produce more Th2 cytokines.\",\n      \"method\": \"TRAF1-/- T cells, cytokine assays, biochemical fractionation showing TRAF1-NIP45 cytoplasmic association, T cell transfer in vivo model\",\n      \"journal\": \"International Immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO plus biochemical interaction, but NIP45 association shown by single Co-IP approach\",\n      \"pmids\": [\"16352630\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TRAF1 interacts with IKK2 (N-terminal aa 1-228 of TRAF1 binds C-terminal aa 466-756 of IKK2); coexpression of TRAF1 and TRAF2 at different ratios affects TRAF2 clustering and NF-κB activity in a dose-dependent manner, suggesting TRAF1:TRAF2 stoichiometry regulates NF-κB.\",\n      \"method\": \"Yeast two-hybrid, mammalian two-hybrid, coimmunoprecipitation, fluorescence imaging of TRAF2 clustering, NF-κB reporter assays\",\n      \"journal\": \"PLoS One\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple interaction methods with functional readout, single lab\",\n      \"pmids\": [\"20856938\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"NF-κB2 mutant p80HT binds the TRAF1 promoter in vivo (chromatin immunoprecipitation) and activates TRAF1 transcription; elevated TRAF1 mediates the anti-apoptotic activity of p80HT, as TRAF1 knockdown abrogates p80HT-mediated anti-apoptosis and restores B cell homeostasis in p80HT transgenic mice.\",\n      \"method\": \"Transgenic mouse model, ChIP, siRNA knockdown of TRAF1, apoptosis assays, TRAF1 and p80HT double-mutant genetic analysis\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP plus transgenic/KO genetic approach with functional rescue\",\n      \"pmids\": [\"17405906\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"A novel TRAF1-ALK fusion protein (Exon 6 of TRAF1 fused to Exon 20 of ALK) was identified by deep RNA sequencing in ALCL; the fusion transcript was confirmed by Sanger sequencing and the fusion protein visualized by Western blot, resulting in cytoplasmic ALK localization.\",\n      \"method\": \"Deep RNA sequencing, Sanger sequencing confirmation, Western blot\",\n      \"journal\": \"Genes, Chromosomes & Cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — molecular characterization of fusion protein at nucleic acid and protein level\",\n      \"pmids\": [\"23999969\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TRAF1 regulates the BRAF/MEK/ERK signaling pathway in non-small cell lung cancer by affecting TRAF2-mediated Lys48-linked ubiquitination of BRAF; loss of TRAF1 decelerates tumor invasion in a urethane-induced lung carcinogenesis model.\",\n      \"method\": \"TRAF1-/- mouse lung carcinogenesis model, ubiquitination assays (Lys48-linked), BRAF/MEK/ERK pathway activation assays\",\n      \"journal\": \"Cancer Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse plus ubiquitination assay, but TRAF2-mediated BRAF ubiquitination link is indirect\",\n      \"pmids\": [\"29748372\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"TRAF1 is required for solar UV-induced ERK5 phosphorylation and AP-1 (c-Fos/c-Jun) activation; TRAF1 expression enhances ubiquitination of ERK5 on Lys184, which is necessary for ERK5 kinase activity; TRAF1-/- mice show significant inhibition of UV-induced skin tumor formation.\",\n      \"method\": \"TRAF1-/- mouse skin carcinogenesis model, ERK5 ubiquitination assay at Lys184, ERK5 kinase activity assays, AP-1 reporter assays\",\n      \"journal\": \"Journal of Investigative Dermatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse plus ubiquitination assay with mutagenesis of Lys184\",\n      \"pmids\": [\"28131816\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"TRAF1 is a critical regulator of JNK/AP-1 signaling downstream of LMP1 TES1 domain in TRAF1-positive lymphoma cells; JNK activation by LMP1 TES1 is blocked by dominant-negative TRAF2 but not TRAF5, and requires TRAF1 reconstitution in TRAF1-negative epithelial cells. This TRAF1 role is specific to LMP1 TES1 and not to CD40 or LMP1 TRADD-interacting domain.\",\n      \"method\": \"Dominant-negative TRAF constructs, TRAF1-negative vs TRAF1-positive cell lines, TRAF1 reconstitution, JNK activation assays\",\n      \"journal\": \"Journal of Virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple cell line contexts and dominant-negative constructs, single lab\",\n      \"pmids\": [\"12502848\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TRAF1 deficiency in both hematopoietic and vascular resident cells attenuates atherosclerosis by impairing monocyte adhesion to endothelium; TRAF1-/- endothelial cells and monocytes show reduced adhesion molecule expression (ICAM-1, VCAM-1), reduced actin polymerization, and reduced CD29 expression.\",\n      \"method\": \"TRAF1-/-/LDLR-/- mouse atherosclerosis model, bone marrow transplantation, static/dynamic adhesion assays, siRNA in human cells\",\n      \"journal\": \"Circulation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse with bone marrow transplantation plus in vitro mechanistic dissection, multiple orthogonal methods\",\n      \"pmids\": [\"20421522\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TRAF1 mRNA translation is regulated by an internal ribosome entry segment (IRES) in its unusually long 5'-UTR (element located between nt -392 and -322 is essential); the chemotherapeutic drug vincristine induces TRAF1 expression by regulating cytoplasmic localization of polypyrimidine tract binding protein, stimulating IRES-dependent translation.\",\n      \"method\": \"Bicistronic reporter assays, deletion mapping of IRES, vincristine treatment, PTB localization assays\",\n      \"journal\": \"Nucleic Acids Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — IRES reporter assays with mutagenesis and deletion mapping, single lab\",\n      \"pmids\": [\"20413583\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TRAF1 promotes myocardial ischemia/reperfusion injury by activating ASK1-mediated JNK/p38 MAPK cascades; TRAF1-/- mice are protected from I/R-induced cardiac dysfunction, inflammation, and cardiomyocyte death, while TRAF1 overexpression in primary cardiomyocytes enhances hypoxia/reoxygenation-induced apoptosis and inflammation.\",\n      \"method\": \"TRAF1-/- mouse I/R model, primary cardiomyocyte overexpression, ASK1-JNK/p38 pathway Western blots\",\n      \"journal\": \"Journal of the American Heart Association\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse plus in vitro overexpression with defined signaling pathway, single lab\",\n      \"pmids\": [\"31650881\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"4-1BB-induced accumulation of CD8 effector T cells in the lung and formation of tissue-resident memory T cells requires TRAF1 and mTOR (rapamycin-sensitive); both Ag and costimulation must be delivered locally, demonstrating TRAF1-dependent mTOR pathway activation downstream of 4-1BB in effector T cell persistence.\",\n      \"method\": \"TRAF1-/- mice, influenza infection/prime-boost model, rapamycin treatment, intratracheal 4-1BB stimulation, lung T cell quantification\",\n      \"journal\": \"Journal of Immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse in vivo model with pharmacological inhibition, but pathway placement partially indirect\",\n      \"pmids\": [\"30867239\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TRAF1 is specifically lost from virus-specific CD8 T cells during chronic HIV/LCMV infection; TGF-β induces posttranslational loss of TRAF1, while IL-7 restores TRAF1 levels; TRAF1 is required for the effect of combination IL-7/anti-4-1BB therapy in reducing viral load.\",\n      \"method\": \"Human HIV patient samples, LCMV mouse model, TRAF1 knockdown in viral controllers, TGF-β/IL-7 treatment, adoptive transfer of TRAF1+ vs TRAF1- memory T cells\",\n      \"journal\": \"The Journal of Experimental Medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — human and mouse models, adoptive transfer with TRAF1+/- cells, multiple orthogonal approaches\",\n      \"pmids\": [\"22184633\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TRAF1 is an NF-κB–induced adaptor protein that lacks the RING finger domain of other TRAF family members and functions as a context-dependent positive or negative regulator of TNF receptor superfamily (especially TNFR2, 4-1BB, CD40) and Toll-like receptor signaling: it forms TRAF1:(TRAF2)₂ heterotrimers that bind cIAP1/2 and modulate TRAF2 subcellular localization and stability, recruits LUBAC to dampen NEMO linear ubiquitination and NF-κB activation downstream of TLRs, is cleaved by caspase-8 at Asp163 to generate a dominant-negative fragment that inhibits NF-κB and amplifies apoptosis, is phosphorylated by PKN1 to facilitate TNFR2 recruitment, directly interacts with ASK1 to promote JNK/p38 pro-death signaling, and is transcriptionally regulated by NF-κB as well as translationally regulated via a 5'-UTR IRES element.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"TRAF1 is an NF-κB–inducible adaptor protein that lacks the RING finger domain present in other TRAF family members and functions as a context-dependent modulator of TNF receptor superfamily, Toll-like receptor, and stress kinase signaling. TRAF1 forms TRAF1:(TRAF2)₂ heterotrimers that enhance cIAP2 recruitment, regulate TRAF2 subcellular localization and stability at lipid rafts, and modulate NF-κB activation downstream of TNFR2, CD40, 4-1BB, and CD30 [PMID:20385093, PMID:12370254, PMID:11672546, PMID:18523273]. TRAF1 recruits LUBAC to dampen NEMO linear ubiquitination and NF-κB activation in TLR signaling, interacts with ASK1 to promote JNK/p38 pro-death cascades in ischemia and metabolic disease, and is cleaved by caspase-8 at Asp163 to generate a dominant-negative fragment that inhibits IKK-dependent NF-κB activation and amplifies apoptosis [PMID:27893701, PMID:24284943, PMID:11098060, PMID:12709429]. TRAF1 expression is transcriptionally driven by NF-κB binding to its promoter and translationally regulated via a 5′-UTR IRES element, establishing feedback circuits that tune inflammatory and survival signaling [PMID:10383449, PMID:9733516, PMID:20413583].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Establishing that TRAF1 forms heterocomplexes with TRAF2 and recruits the NF-κB inhibitor A20, revealing TRAF1 as a scaffold for negative feedback in NF-κB signaling rather than a simple signal transducer.\",\n      \"evidence\": \"Reciprocal Co-IP with mutagenesis and NF-κB reporter assays in transfected cells; EBV LMP1 cytoplasmic domain dissection identified the PXQXT/S TRAF-binding motif\",\n      \"pmids\": [\"8692885\", \"8943365\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structural basis for TRAF1-TRAF2 heterotrimerization at this stage\", \"Stoichiometry of heterocomplex unknown\", \"In vivo relevance of A20 recruitment via TRAF1 not tested\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Demonstrating in vivo that TRAF1 overexpression inhibits antigen-induced CD8 T cell apoptosis and that TRAF1/TRAF2 activate NF-κB through CD30 domain 2, placing TRAF1 as a costimulatory adaptor for TNFR superfamily members.\",\n      \"evidence\": \"Transgenic mouse CD8 T cell apoptosis assay; CD30 cytoplasmic domain mutagenesis with NF-κB reporters\",\n      \"pmids\": [\"9151703\", \"9032281\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Receptor-specific versus general anti-apoptotic role not distinguished\", \"Endogenous TRAF1 loss-of-function not yet tested\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Identifying TRAF1 as a direct NF-κB transcriptional target that cooperates with TRAF2/cIAP1/cIAP2 to suppress caspase-8, establishing the NF-κB → TRAF1 anti-apoptotic feedback loop.\",\n      \"evidence\": \"Cotransfection/reporter assays with dominant-negative constructs and NF-κB inhibition, apoptosis readout in TNF-stimulated cells\",\n      \"pmids\": [\"9733516\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of caspase-8 suppression by TRAF1 not defined\", \"Relative contribution of TRAF1 vs cIAP1/2 unresolved\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Mapping NF-κB binding sites in the TRAF1 promoter and showing that TRAF1 overexpression prolongs JNK activation while inhibiting NF-κB, revealing TRAF1 as a pathway-selective feedback regulator.\",\n      \"evidence\": \"EMSA, promoter-luciferase reporters, RNase protection assays, JNK/NF-κB activation with TRAF1 overexpression/deletion constructs\",\n      \"pmids\": [\"10383449\", \"10544244\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which TRAF1 prolongs JNK while restraining NF-κB not resolved\", \"Overexpression artifacts cannot be excluded for NF-κB inhibition\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Discovering that caspase-8 cleaves TRAF1 at Asp163 during death receptor signaling, generating a C-terminal dominant-negative fragment that blocks NF-κB and amplifies apoptosis — converting TRAF1 from protector to pro-death effector.\",\n      \"evidence\": \"In vitro caspase cleavage assays, site-directed mutagenesis of LEVD163, overexpression of fragments with NF-κB and apoptosis readouts\",\n      \"pmids\": [\"11098060\", \"10692572\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological stoichiometry of cleavage fragments unclear\", \"Whether caspase-8 cleavage of TRAF1 is required for apoptosis in vivo untested\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"TRAF1 knockout mice revealed that TRAF1 is a negative regulator of TNFR2 signaling in vivo: TRAF1-deficient T cells hyper-respond to TNF via TNFR2, and skin shows TNF hypersensitivity, settling the question of whether TRAF1 is predominantly pro-survival or inhibitory.\",\n      \"evidence\": \"TRAF1-/- mouse generation, T cell proliferation/NF-κB/AP-1 assays, skin TNF necrosis challenge\",\n      \"pmids\": [\"11672546\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TRAF1 loss affects TNFR1 signaling in vivo remains unclear\", \"Cell-type-specific versus systemic contributions not dissected\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Resolving how TRAF1 modulates TRAF2 function: TRAF1 displaces TRAF2 and CD40 from lipid rafts and prevents TRAF2 degradation, sustaining prolonged signaling — explaining the paradox of TRAF1 acting as both positive and negative regulator depending on signal duration.\",\n      \"evidence\": \"Lipid raft fractionation in TRAF1-/- dendritic cells, RING finger mutants, JNK and NF-κB time-course assays\",\n      \"pmids\": [\"12370254\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether raft displacement is direct or mediated by another factor unknown\", \"Kinetics of TRAF2 stabilization by TRAF1 not quantified\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identifying the IKK complex as a direct target of caspase-cleaved TRAF1: the C-terminal fragment inhibits IKK activation, while full-length TRAF1 constitutively associates with IKK2 via its N-TRAF domain, mechanistically explaining how cleavage switches TRAF1 function.\",\n      \"evidence\": \"Co-IP of TRAF1 with IKK complex, kinase assays, fragment overexpression with NF-κB reporters\",\n      \"pmids\": [\"12709429\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Endogenous cleavage fragment–IKK interaction not demonstrated\", \"Structural basis for N-TRAF domain–IKK2 interaction unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Establishing TRAF1 as essential for 4-1BB costimulatory signaling in CD8 T cells: TRAF1 is required for ERK activation, Bcl-xL upregulation, and survival during viral infection, and PKN1 phosphorylation of TRAF1 controls its recruitment to TNFR2.\",\n      \"evidence\": \"TRAF1-/- mice with viral infection model and 4-1BB ligation; in vitro/in vivo kinase assays with phospho-site mutagenesis for PKN1–TRAF1\",\n      \"pmids\": [\"18523273\", \"18429822\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"PKN1 phosphorylation site on TRAF1 not mapped to a specific residue in the publication\", \"Whether PKN1 regulation of TRAF1 applies to 4-1BB pathway untested\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Structural resolution of TRAF1:(TRAF2)₂:cIAP2 complex showed that TRAF1 forms a 1:2 heterotrimer with TRAF2 that enhances cIAP2 binding, providing the atomic basis for TRAF1's modulatory role; concurrently, TRAF1 was shown to regulate atherosclerosis through monocyte-endothelial adhesion and to undergo IRES-dependent translation.\",\n      \"evidence\": \"X-ray crystallography with mutagenesis (TRAF1:TRAF2:cIAP2); TRAF1-/-/LDLR-/- mouse atherosclerosis model with bone marrow chimeras; bicistronic IRES reporter assays with deletion mapping\",\n      \"pmids\": [\"20385093\", \"20421522\", \"20413583\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length TRAF1:TRAF2 complex structure not available\", \"IRES trans-acting factors beyond PTB not identified\", \"Whether TRAF1:TRAF2 stoichiometry changes in vivo during signaling unknown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Demonstrating that TRAF1 has opposing roles in classical versus alternative NF-κB: it promotes classical NF-κB via 4-1BB but restricts constitutive NIK activation by participating in the cIAP1/2:TRAF2:TRAF3:NIK degradation complex, unifying apparently contradictory phenotypes.\",\n      \"evidence\": \"TRAF1-/- T cells, NIK siRNA rescue, 4-1BB stimulation with cIAP1-dependent TRAF3 degradation assays\",\n      \"pmids\": [\"22570473\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct biochemical demonstration of TRAF1 within the NIK degradation complex lacking\", \"Whether TRAF1's role in alternative NF-κB extends beyond T cells unknown\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Revealing a non-immune function: TRAF1 directly binds ASK1 and promotes neuronal apoptosis after ischemia by activating JNK and inhibiting Akt, expanding TRAF1's role beyond immune signaling to stress-induced cell death.\",\n      \"evidence\": \"Co-IP of TRAF1-ASK1, TRAF1-/- and transgenic mice in stroke model, JNK/Akt pathway assays\",\n      \"pmids\": [\"24284943\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TRAF1 activates ASK1 directly or relieves thioredoxin inhibition unknown\", \"Structural basis for TRAF1-ASK1 interaction not determined\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrating that TRAF1 serves as a platform for LUBAC recruitment in EBV LMP1 signaling, leading to M1- and K63-linked ubiquitination of TRAF1 complexes and recruitment of NEMO, A20, and ABIN1 — connecting TRAF1 to linear ubiquitin-dependent signaling.\",\n      \"evidence\": \"Proteomic analysis of immunopurified TRAF1 complexes, ubiquitin linkage-specific antibodies, shRNA knockdown with LCL growth assays\",\n      \"pmids\": [\"25996949\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TRAF1 is itself a direct ubiquitination substrate or scaffold for other substrates not resolved\", \"LUBAC recruitment mechanism (direct vs TRAF2-mediated) debated\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Establishing TRAF1 as a direct negative regulator of TLR/LUBAC signaling independent of TNF: the TRAF1 MATH domain binds SHARPIN, HOIP, and HOIL-1 to block NEMO linear ubiquitination and NF-κB activation; TRAF1-/- mice are hypersusceptible to LPS septic shock.\",\n      \"evidence\": \"Direct binding assays of TRAF1 MATH domain with LUBAC components, Co-IP, TRAF1-/- mouse LPS challenge, human monocyte disease-SNP validation\",\n      \"pmids\": [\"27893701\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TRAF1-LUBAC interaction is competitive or allosteric not defined\", \"Role of TRAF1 in other TLR pathways beyond TLR4 not explored\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Extending TRAF1-ASK1 axis to metabolic disease: TRAF1 promotes hepatic steatosis through ASK1-p38/JNK activation, and ASK1 inhibition fully rescues TRAF1-driven insulin resistance and lipid accumulation.\",\n      \"evidence\": \"Global TRAF1-/- and liver-specific transgenic mice on HFD/ob/ob background, ASK1 pharmacological inhibitor rescue\",\n      \"pmids\": [\"26860405\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct phosphorylation or activation mechanism of ASK1 by TRAF1 not defined\", \"Whether TRAF1-ASK1 interaction in liver involves TRAF2 not tested\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Crystal structures of TRAF1 TRAF domain alone and in complex with TANK peptide confirmed the Px(Q/E)xT binding motif and showed similar affinity to TRAF2, providing the first structural framework for receptor/adaptor selectivity.\",\n      \"evidence\": \"X-ray crystallography with quantitative binding measurements\",\n      \"pmids\": [\"27151821\", \"28155233\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structure of full-length TRAF1\", \"How TRAF1 distinguishes between different receptor cytoplasmic tails structurally unclear\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Extending TRAF1-ASK1 pro-death axis to cardiac ischemia/reperfusion injury, and establishing TRAF1-dependent mTOR activation downstream of 4-1BB for tissue-resident memory CD8 T cell formation in the lung.\",\n      \"evidence\": \"TRAF1-/- mouse cardiac I/R model with cardiomyocyte overexpression; TRAF1-/- mice in influenza prime-boost model with rapamycin\",\n      \"pmids\": [\"31650881\", \"30867239\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether TRAF1-mTOR link is direct or mediated through ERK/PI3K unknown\", \"Cardiac TRAF1-ASK1 mechanism largely inferred from hepatic/neuronal models\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key open questions include: the structural basis of full-length TRAF1 and how it differs from other TRAFs lacking the RING domain; the molecular mechanism by which TRAF1 activates ASK1; the relative contributions of TRAF1-LUBAC versus TRAF1-TRAF2 complexes to receptor-specific NF-κB regulation; and whether post-translational modifications beyond PKN1 phosphorylation and caspase cleavage control TRAF1 switching between pro-survival and pro-death functions.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No full-length TRAF1 structure available\", \"Mechanism of ASK1 activation by TRAF1 not biochemically defined\", \"Comprehensive post-translational modification map of TRAF1 lacking\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 2, 3, 13, 14]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [4, 5, 11, 14, 22]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [5, 25]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 2, 4, 7, 10, 13, 14, 18]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [12, 14, 32, 36]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [0, 6, 8, 9, 18]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [28, 29, 30]}\n    ],\n    \"complexes\": [\n      \"TRAF1:(TRAF2)2:cIAP2 heterotrimer\",\n      \"cIAP1/2:TRAF2:TRAF3:NIK repressor complex\",\n      \"TRAF1:LUBAC complex\"\n    ],\n    \"partners\": [\n      \"TRAF2\",\n      \"BIRC3\",\n      \"TNFAIP3\",\n      \"MAP3K5\",\n      \"SHARPIN\",\n      \"RNF31\",\n      \"RBCK1\",\n      \"PKN1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}